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COMPUTER SIMULATION STUDIES IN FLUID AND CALCIUM
REGULATION AND ORTHOSTATIC INTOLERANCE
FINAL REPORT
1.0 INTRODUCTION
This is the final report for Contract NAS9-17151 which was in effect from May
7, 1984, to May 7, 1985, with the National Aeronautics and Space Adminis-
tration. The statement of work for this contract is contained in Appendix A
of this report and involves work in three major areas of physiological concern
which have been subdivided into six tasks. Each of these tasks was
accomplished and the work has been transmitted to NASA in twenty-three
Technical Information Releases which are listed in Appendix B. Because of the
detailed nature of these study reports, the present final report will only
attempt to summarize the overall effort.
The thread that ties these tasks together is the systems analysis approach to
physiological research, a theoretical approach that utilizes mathematical
modeling and computer simulation as its major tools. These mathematical
models and related data systems have been under development by NASA and the
present contractor for a number of years under various
*
contracts. In addition to the development of operational models, an
important part of the past and current effort has been in applying these
models to the problems of space physiology. Specifically, they have proved to
be valuable tools in integrating much of the data from space flight (Skylab)
and ground-based tests. They have assisted in identifying the hypotheses and
design of experiments which are currently being readied for flight, and they
have provided insight into new approaches for crew health maintenance. A
major focus has been the evolution of a multi-disciplined, integrated
hypothesis for adaptation to the weightlessness environment (Figure 1-1).
* See references listed under "Final Report" (7-11).
An executive summary of this overall effort was completed and released during
the current contractual period, "An Integrated Analysis of the Physiological
Effects of Space Flight" (28). An additional document was also released that
provides an introduction to modeling and simulation to those unfamiliar with
this topic, "The Modeling and Simulation of Feedback Control Systems"
(29).
This report is structured to correspond to the major areas of physiological
concern delineated in the Statement of Work. Section 2.0 concerns Body Fluid
and Blood Volume Regulation, Section 3.0 concerns Orthostatic Intolerance and
Cardiovascular Deconditioning, Section 4.0 concerns Calcium Regulation and
Bone Atrophy, and Section 5.0 concerns Potential Contributions of Physiologic
Math Models to Future Flight Experiments. Each section references the
applicable contract task numbers, as well as separately published study
reports. Recommendations for future work are contained in each section as
appropriate. As part of a related task, the contractor recently compiled a
set of candidate flight experiment objectives for the life science
disciplines. Inasmuch as systems analysis and mathematical modeling provided
the organizing principles for generating this compilation, and because it is
in accord with the contract task on experimental design, it has been included
as Appendix C.
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2.0 BODY FLUID AND BLOOD VOLUME REGULATION
There are two tasks in this area of physiological concern as delineated in the
Statement of Work (See Appendix A). -
Task 1 - Development of an Integrated Analysis of Blood Volume Regulation
During Space Flight
Task 3 - Design of Key Experiments Related to Body Fluid and Blood Volume
Regulation
Task 1 is addressed in this section, while the results of Task 3 are presented
in Section 5.0.
2.1 INTRODUCTION
Central to an understanding of the overall physiological response to weight-
less exposure, is the elucidation of the physiologic mechanisms underlying the
loss of blood volume during space flight. The factors responsible for the
approximately 10 percent loss of blood volume observed in crewmembers return-
ing from space, while not well understood, are believed to be a result of
normal feedback processes involving circulatory, renal, endocrine, hematol-
ogic, and other related systems (32). Although never measured directly during
flight, blood volume is believed to be reduced acutely, due to pure plasma
volume loss which is followed by a more gradual loss of red cells (17). The
result of this blood volume loss has important negative cardiovascular con-
*
sequences in exercise and orthostatic performance (14). The etiology of the
plasma volume loss is probably a reponse to headward fluid shifts and upper
body circulatory volume overload. The actual metabolic routes of body-fluid
loss may be a combination of disturbances in fluid intake, renal excretion,
and perhaps under certain conditions, evaporative water loss, as well.
* These cardiovascular issues are addressed in more detail under Tasks 4 and 5
of this report.
However, in spite of the central role that blood volume plays in the space-
flight response, and in spite of the large number of studies that have been
devoted to measuring plasma volume or red-cell mass loss during water
immersion, bed rest, and space flight, there has been no rigorous attempt to
integrate the findings of these studies in the context of a unified theory of
blood volume regulation. Blood volume regulation is typically discussed in
terms of either plasma volume regulation, (that is, during deydration, fluid
loading, or orthostasis) or erythropoietic regulation (that is, during
phlebotomy, hypoxia, or hemolytic anemia). Space flight, however, seems to
affect, in a fundamental way, both of these systems. The overall blood volume
regulation in weightlessness is the subject of Task 1 of the Statement of
Work.
2.2 APPROACH
The lack of frequent opportunities for in-flight experimentation has created •'•
an emphasis on simulating space-flight effects by using ground-based experi-
mental analogs of zero-g as well as by developing and using mathematical
models. Water immersion studies in man and head-down tilt studies in both man
and animals have been used to simulate short-term adaptation to weightless-
ness, while bed-rest studies have been used to simulate longer-term space-
flight observations (12,18,37). Mathematical models, particularly those
developed by the contractor, have successfully served to analyze and interpret
these one-g analog studies, as well as the space-flight data (46).
Two models in particular, the Guyton model of fluid and electrolyte control
(13), and the Leonard model of erythropoiesis control (20) have been used
extensively in the analyses and interpretations of data related to space
flight and its one-g analogs. The original Guyton model has been previously
modified by this contractor to reflect new physiological developments and to
allow the simulation of zero-g effects (19,45). This model and its
modifications were developed by combining integrative and logical
characteristics of homeostatic feedback theory with mathematical
representations of the body's control systems. The erythropoiesis model was
developed in support of NASA's hematology research program. This model
incorporates the most current understanding of the dynamics of red-cell
production and the associated feedback regulation based on the balance between
tissue oxygen supply and demand. Together, these two models provide the
theoretical basis for a study of the total loss of blood volume during space
flight and its analogs, including an analysis of the separate but related
changes in plasma volume and red cell mass.
The fluid and electrolyte model based upon Guyton's work contains an excellent
description of the regulation of plasma volume, but is incomplete with regard
to its erythropoiesis-control algorithm. Therefore, the approach taken to
complete this task was to incorporate the superior "stand-alone" model of
erythropoiesis control with that of the modified Guyton model. This hybrid
model, along with the stand-alone model of erythropoiesis, were used to
perform a series of analyses designed to address the causes and consequences
of blood volume regulation as it pertains to weightlessness. These analyses
resulted in the preparation of eleven reports/presentations over the course of
the contract period. These reports/presentations can be grouped into two
major categories as listed below - those related to Fluid/Electrolyte
Regulation, and those related to Erythropoiesis Regulation. They embody the
essence of Task 1 and provide an integrated view of blood volume regulation.
A. Fluid/Electrolyte Regulation
Leonard, J. I. Mathematical Modeling of Fluid-Electrolyte
Alterations During Weightlessness, TIR 2114-MED-4001. (24)
Leonard, J. I. Analysis of Head-Down Tilt as an Analog of
Weightlessness Using a Mathematical Simulation Model, TIR
2114-MED-4003. (26)
Leonard, J. I. Fluid-Electrolyte Responses During Prolonged Space
Flight: A Review and Interpretaion of Significant Findings, (TIR
2115-MED-5008. (30)
Leonard, J. I. The Behavior of Renal-Regulation Hormones During
Hypogravic Stress, TIR 2115-MED-5002. (31)
B. Erythropoietic Regulation
Leonard, J. I. Systems Analysis of the Erythropoietic Responses to
Weightlessness- Vol. I.: Mathematical Model Simulations of the
Erythropoietic Responses to Weightlessness, TIR 2114-MED-5003). (32)
Leonard, J. I. A Systems Analysis of the Erythropoietic Responses to
Weightlessness, Vol II.: Description of the Model of Erythropoiesis
Regulation, TIR 2114-MED-5004. (33)
Nordheim, A. W. A Detailed Analysis of the Erythropoietic Control
System in the Human, Squirrel Monkey, Rat and Mouse, TIR
2114-MED-5010. (38)
Nordheim, A. W. Use of Modeling in Developing Experimental Protocols
Appropriate for Space Flight Experiments, 1983. (39)
2.3 RESULTS
The following reports/presentations, grouped as shown above, were prepared in
response to Task 1. Short abstracts of each report are presented below to
provide a summary of the work performed, the type of information available,
and how that information is related to the contract task.
2.3.1 Fluid/Electrolyte Regulation
a) Leonard, J.I. Mathematical Modeling of Fluid-Electrolyte Alterations
During Weightlessness, TIR 2114-MED-4001. (24)
This report concentrates on one particular discipline that has been
intensively studied in weightlessness - the fluid/electrolyte metabolism and
the renal-endocrine control of that system as it adapts to a new environment.
The report defines the physiological system of interest and discusses the
models that have been particulary useful (specifically, the Guyton model of
circulatory, fluid, and electrolyte control) and the Leonard model of
erythropoiesis control in examining that system. However, the main emphasis
of the report is not on the details of the model or the simulation studies.
Rather, the primary conclusions of the computer studies are examined in terms
of their physiological meaning and in the context of achieving a better
understanding of physiological behavior in weightlessness.
A discussion of the major ground-based analogs of weightlessness are included:
for example, head-down tilt, water immersion, and bed rest, as well as a
comparison of findings from those studies with space flight. Several
important zero-g phenomena are described in detail, including acute fluid
volume regulation, blood volume regulation, circulatory changes, longer-term
fluid-electrolyte adaptations, hormonal regulation, and body composition
changes. Hypotheses are offered to explain the major findings in each area
and these are integrated into a larger hypothesis of space-flight adaptation.
These hypotheses are testable and have provided a basis for some of the next
generation of space-flight studies concerning blood volume regulation during
zero-g exposure. Figure 2-1 is an important example of an hypothesis that has
been formulated as a result of modeling and awaits to be tested in space. It
concerns the mechanisms of plasma volume loss in space flight and, therefore,
represents an important portion of the overall zero-g blood volume regulatory
theory. The remaining elements of the picture are discussed in the next
subsection below. The report provides the conceptual foundation for the
contractual tasks concerning fluid-electrolyte metabolism (Task 1 and 3),
blood volume regulation (Task 1), and cardiovascular regulation (Tasks 4 and
5).
b) Leonard, J.I. Analysis of Head-Down Tilt as an Analog of
Weightlessness Using a Mathematical Simulation Model,
TIR 2114-MED-4003. (26)
Anti-orthostasis or head-down tilt of a moderate degree has been used as a
ground-based analog of weightless space flight to study headward fluid shifts,
decreased plasma volume, orthostatic intolerance, and musculo-skeletal
degradation. In this study, the modified Guyton model was used to help
interpret the head-down tilt response and relate the elicited physiological
changes to those which occur in space flight. By using the same mathematical
model to simulate both space flight and ground-based experimental analogs of
space flight, it is possible to test hypotheses regarding mechanisms and
control systems, and thus, discern the major characteristics of these
stresses, their similarities and differences.
Two different experimental studies were employed in this paper to validate the
model. The first was a 24-hour -5° head-down tilt study (1,37) and the second
was a 7-day -6° head-down bed rest study (47). The simulations of both of
these studies demonstrated changes in the fluid volume, hemodynamic,
electrolyte, hormone and renal characteristics that are in good agreement with
direct experimental results. Figure 2-2 shows the results of a head down tilt
simulation. The fluid-shift hypothesis of Figure 2-1 that explains the
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reduction In plasma volume was elucidated by studying model behavior as shown
in Figure 2-2. This is an important simulation, because it represents a
detailed prediction of the acute events of cardiovascular and fluid regulation
during the first day of space flight. A number of flight experiments are
currently being readied to examine this early period of weightlessness. The
veracity of the model in its predictions is suggested by the good agreement
between data and model behavior for head-down tilt, as shown in Table 2-1.
Other issues which were addressed, included the dynamic changes of venous
pressure and cardiac output, the extent of central hypervolemia during long
term zero-g exposure, the existence of an early diuresis (which is yet to be
measured), the mechanisms which alter the renal-regulating hormones during the
short-term and long-term periods, the significance of potassium loss on other
zero-g responses, and the role of transcapillary filtration in adjusting fluid
shifts. This study illustrates the use of mathematical models as an
interpretive and analysis technique for assisting experimental research for
space life science.
c.) Leonard, J.I. Fluid-Electrolyte Responses During Prolonged Space
Flight: A Review and Interpretation of Significant Findings,
TIR 2114-MED-5008. (30)
This document summarizes the most important results of the Skylab studies
related to fluid-electrolyte regulation. These data became the starting point
of an extensive systems analysis to study adaptation to the weightlessness
environment. A brief summary of the systems analysis study, including an
interpretation of Skylab results, is also included.
Most of the results contained in this document have been published by the
Skylab principal investigators, but in a different format. New analyses of
these data are presented, describing both the short and long-term responses to
space flight. Developing a composite picture of these responses, based on the
nine Skylab crewmen, was preferable in most instances to explaining the
differences between flights. Therefore, instead of presenting the individual
crew data for day-by-day biochemical changes in blood and urine (which has
been previously reported), this information has been computed as daily
nine-man averages so that trends, if they exist, can be more easily discerned.
Figures 2-3 to 2-6 represent 9 crew-man averages of body water and electrolyte
11
TABLE 2-1
COMPARISON OF SIMULATION AND EXPERIMENTAL RESPONSE
FOR 24-HOUR HEAD-DOWN (-5°) TILT STUDY
QUANTITY VALUE @ 24-HOURS COMPARED TO CONTROL
HEAD-DOWN TILT MODEL
FLUID SHIFTS
TOTAL BODY WATER -1300ml -1130ml
LEG BLOOD VOLUME ND - 256ml
LEG INTERSTITIAL VOLUME ND - 454 ml
TOTAL LEG VOLUME - 900ml - 710ml
TOTAL BLOOD VOLUME - 425 ml - 563 ml
HEMATOCRIT + 7.5% + 12.5%
URINE RATE, 1ST 8 HR/24 HR 127% 190%
HEMODYNAMICS
CARDIAC OUTPUT - 7.8% - 11.1%
STROKE VOLUME - 8.5% - 9.8%
HEART RATE 0% 1.4%
ARTERIAL PRESSURE + 3% + 3%
CENTRAL VENOUS PRESSURE - 49% - 9%
LEFT ATRIAL PRESSURE ND - 50%
PERIPHERAL RESISTANCE + 11.3% + 16.0%
HORMONES
ANGIOTENSIN + 2 5 % + 27%
ALDOSTERONE + 35% + 1 7 %
ADH + 57% + 3%
NATRIURETIC FACTOR ND + 13%
ND = NOT DETERMINED
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FIGURE 2-6
A composite water balance analysis of the Skylab crew (N=9). Percent
changes from control are indicated for the first 28 days and the two
weeks postflight. Also shown is the average three month mean that
provides insight into long-term changes of intake, excreta and evapor-
ative water loss during a time when the water balance is essentially
zero. Intake includes drinking water, water in food and metabolically
produced water. Output includes both urine and fecal water. Evaporative
water loss was estimated indirectly, (Leonard, 1977).
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changes, plasma hormonal responses, urinary parameters, and composite water
balance responses of crew-members exposed to 30 days of zero-g. Questions
concerning these observations were identified,.categorized, and interpreted.
These issues formed the basis of a subsequent simulation model analysis, (31)
as described below, as well as helping to design the next generation of
space-flight experiments.
d) Leonard, J.I. The Behavior of Renal-Regulation Hormones During
Hypogravic Stress, TIR 2114-MED-5002. (31)
Homeostatic correction of fluid volume disturbances in zero-g results in
reductions of total body water and plasma volume as well as major electrolytes
such as sodium. Regulation of these quantities require the participation of
renal-thirst mechanisms in general, and hemodynamic, neural, and hormonal
controllers in particular. A group of renal regulating hormones, consisting
of renin-angiotensin, aldosterone, and anti-diuretic hormone (ADH) have been
the focus of many space-flight related studies. An understanding of their
role promises to reveal much about the mechanisms which control renal
excretion of fluids and electrolytes during exposure to weightlessness.
However, the behavior of these hormones has been difficult to interpret or to
reconcile with endocrine data obtained from one-g analogs of weightlessness
such as, water immersion, head-down tilt, and bed rest. The purpose of this
study was to examine these data, describe the major characteristics of the
hormone responses, and to assess the controlling mechanisms.
The first section of this report concerns the detailed analysis of one of the
hormones, ADH. The second section extends the analysis to include aldosterone
and angiotensin, as well as to propose a more generalized theory of
renal-endocrine behavior during hypogravic stress. The primary techniques
used in this analysis were a series of computer simulations using the modified
Guyton model.
The overall conclusion of this study is that each of the renal-regulating
hormones appear to repond acutely to volume disturbances and chronically to
electrolyte disturbances. During hypogravic maneuvers this leads to an
initial suppression of hormone levels and a long-term effect which varies
depending on metabolic factors such as diet, sweat loss, physical activity,
17
and muscle atrophy which can alter the plasma electrolytes. In addition, the
simulations reveal that if fluid pressure effects rapidly normalize, a
transition phase may exist which leads to a dynamic multi-phasic endocrine
response. As indicated in Figure 2-7, these hormones are part'of a much
larger feedback system that can apparently regulate circulatory extracellular
disturbances of various kinds. This diagram illustrates three distinct types
of control mechanisms, including hormones, autonomies, and hemodynamics which
act to maintain extracellular volume and composition, as well as blood
pressure and renal output. Because of these complex and often competing
stimulating factors, and the different modes of response, it is difficult to
predict the behavior of hormone levels in the plasma or urine, except perhaps
by using computer models. Indeed, this may explain why variable findings are
often reported for apparently similar bed-rest and head-down tilt studies.
Verification of this hypothesis requires the collection of data which have not
yet been collected, including measurements of endocrine behavior during the
acute phase of space flight and measurement of various circulatory pressures
duing the longer-term periods of hypogravity. In addition to a knowledge of
electrolyte behavior in the body fluids, it is crucial to control such
metabolic factors as diet, physical activity, and circadian rhythms.
2.3.2 Erythropoietic Regulation
a) Leonard, J.I. Systems Analysis of the Erythropoietic Responses to
Weightlessness Vol. I.: Mathematical Model Simulations of the
Erythropoietic Responses to Weightlessness, TIR 2114-MED-5003. (32)
b) Leonard, J.I. A Systems Analysis of the Erythropoietic Responses to
Weightlessness Vol II.: Description of the Model of Erythropoiesis
Regulation, TIR 2114-MED-5004. (33)
Beginning in 1974 and continuing to the present, a systems analysis research
program has focused on the hematological problems of space flight.
Specifically, it was designed to understand the mechanisms underlying the most
significant hematological finding of clinical importance: that is, the
reduction in red cell mass. The cornerstone of this analysis was the
development and testing of a mathematical model describing the regulation of
erythropoiesis. Simulations performed with this model were used .to examine
the theoretical behavior of erythropoietic regulation so as to provide a means
to permit hypotheses to be mathematically tested as a preliminary step in
accounting for the "anemia of space flight."
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The first document (32) contains a review of all relevant space-flight
data and a set of testable hypotheses which attempt to explain how red cell
mass decreases in space flight. The second document (33) describes the
details, both mathematical and physiological, of the formulation of the
mathematical model used in these studies.
The first document consists of contains several major sections, including a
review of previous space-flight findings, the role of tissue oxygenation, and
other theoretical considerations of erythropoiesis, hypotheses accounting for
the effects of space flight, and a review of the computer simulations of
of experimental studies. Part of the study included a valuable collaboration
between systems analysts and biological researchers, which permitted testing,
in the biological system, hypotheses suggested by the computer model. Results
from a number of experimental studies, each characterized by a reduced red
cell mass, or suppressed erythropoietic activity, were examined. These
included not only space-flight investigations, but also those of bed rest, red
cell infusions, dehydration, and descent-from-altitude. The simulation model
was valuable in revealing the pathways which were common to all of these
situations and provided a quantitative basis for testing whether the same
mechanisms were operative in space flight. Figure 2-8 is a representation of
the pathways which may be involved in the loss of red cell mass.
The hypothesis most favored in this study is that shifts in plasma volume
accompanying hypogravic maneuvers results in an observed mild
hemoconcentration which can eventually lead to increased oxygen supply to the
renal sensor and cause suppression of erythopoietin and red cell production.
The model suggests that red cell mass will stabilize as hematocrits normalize.
This process can, therefore, be explained in terms of normal feedback
regulation of the erythropoietic system in the face of sustained decreases in
plasma volume. Validations of this theory will require, at the very least,
confirmation that erythropoietin levels decrease during space flight. Other
factors which may have enhanced oxygen delivery shifts in blood flow, P50» and
arterial oxygen partial pressure, but no data exist at present concerning
these effects. Also, it is believed that inadequate dietary intake or
exercise can also suppress red cell mass for reasons that are not well under-
stood. Alternatively, it is possible that an acute increase in red cell
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during space flight.
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destruction could have occurred during flight due to hemorrhage, hemolysis, or
sequestration. However, the model suggests that this factor would be
contributory to, but not responsible for, the overall zero-g loss of red cell
mass.
The concept that red cell mass may be regenerated during space flight, as
proposed for the Skylab missions, was examined in detail, and found to be
based on misleading assumptions and incomplete interpretation of the data.
However, still lacking is a clear understanding of why the three Skylab crews
differed in their overall decrements in red cell mass.
For the present, it appears that an answer to the loss of red cell mass will
involve an understanding of the basic processes of erythropoiesis, including
the role of oxygen transport, as well as the regulation of plasma volume and
total blood volume. In order to isolate the basic controlling mechanisms, the
subtle changes in energy balance and water balance need to be carefully
controlled in future space-flight experiments. Also, an erythropoietin assay
with improved resolution is required in order to obtain definitive data
regarding this important hormonal regulator.
c) Nordheim, A.W. A Detailed Analysis of the Erythropoietic Control
System in the Human, Squirrel Monkey, Rat and Mouse, TIR
2114-MED-5010. (38)
New experimental studies of body fluid and blood volume regulation during
space flight are being considered which utilize, not only human subjects, but
animals such as the laboratory mouse, rodent, and squirrel monkey. Mathe-
matical models representing the human and murine erythropoietic systems have
been previously developed (21,33) and have been useful in elucidating the
mechanisms involved in the control of erythropoiesis and, therefore, blood
volume regulation, under a variety of stress situations, including space
flight. In order to better understand the erythropoietic system and the
previous space-flight results, and to help analyze the data from these new
multi-species experiments, a uniform, species-independent, modeling approach
to the erythropoiesis system has been developed. This report presents the
description of the mathematical formulation of the species-independent model
of erythropoiesis regulation, the solutions to the steady-state and dynamic
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versions of the model, as well as the individual species-specific models for
the human, squirrel monkey, rat, and mouse. The analysis portion of the
report is composed of two parts. The first part is a detailed sensitivity
analysis of the species-independent model response to parameter changes and '
how these responses change from species to species. The second part of the
study presents an analysis of the species-to-species response of the model to
a series of simulated stresses related to the understanding of erythropoietic
control systems and the stress of space flight (that is, long-term hypoxic
exposure, red cell infusion/loss, infusion of erythropoietin, and plasma
volume depletion). Also included in the report as appendices are the
derivations of the static and dynamic sensitivity equations.
d) Nordheim, A.W. Use of Modeling in Developing Experimental Protocols
Appropriate for Space Flight Experiments. (39)
The development of Life Sciences Experiments for space flight is expensive and
the number and frequency of flight opportunities for experiments are limited.
For these reasons, it is necessary to maximize the scientific yield of each
flight opportunity. This presentation highlighted how modeling can help to
maximize the scientific return of flight experiments by helping to analyze
existing experimental data, by allowing multiple simulations to be performed,
by helping to develop and identify hypotheses, and by providing a means by
which alternative hypotheses concerning known or expected space-flight results
can be compared. In addition, modeling can be used during the development
phase of an experiment; to help design the experiment so that the results will
be able to distinguish between competing hypothesis; to help in the allocation
of inflight resources in order to achieve the greatest scientific return; and
to help design the most appropriate ground-based experimental controls. In
those cases where multiple experiments will be conducted in a single space
flight, modeling can be used to investigate the impact that other
investigations might have on experimental results. This information can be
used, if necessary, to redesign the experiments, in order to reduce the
inter-experiment interferences. Physiological models have been used in the
analysis and design of several previous and pending space-flight investi-
gations. These include models and experiments relating to red blood cell
regulation, fluid/electrolyte control, cardiovascular control, and calcium
regulation. The presentation included an example of how the model of red
23
blood cell regulation was used to help design and analyze an experiment flown
on the first Spacelab mission. Table 2-2 shows the original blood draw
protocol proposed for the Spacelab-One (SL-1) experiments and the final
protocol that was used for the mission. The original protocol was revised
based upon a series of simulation studies performed by this contractor
followed by a reassessment of the blood draw requirements by the SL-1
Principal Investigators. Figure 2-9 shows the results of three simulation
studies performed in order to evaluate the impact that the blood draw
protocols might have on one of the SL-1 experiments (i.e., INS-103, the
erythrokinetics experiment). Table 2-3 presents a comparison of the
simulation results for the two blood draw protocol shown in Table 2-2, high-
lighting the impact that the protocols would have on the expected results of
INS-103.
2.4 CONCLUSIONS
Data from the Skylab Life Sciences experiments suggest that there is a tight
coupling between the regulation of red cell mass and plasma volume. On these
missions, the plasma and red cell losses had opposite trends, with plasma
losses getting larger and red cell losses becoming smaller as a function of
time in space (17). However, the total decrement, expressed as blood volume
loss, appeared to have stabilized after one month; thereafter, the overall
blood volume loss was not dependent on zero-g exposure time. These
experimental results are summarized in Figure 2-10.
A tentative hypothesis explaining this phenomenon is described below. The set
point for blood volume regulation is reduced in weightlessness because of the
tendency for central circulatory volume overload. Plasma volume losses are
achieved by complex renal-thirst mechanisms (see Figure 2-1), while
suppression of erythropoiesis occurs due to changes in tissue oxygen demands
brought about by changes in the characteristics of the circulating blood
(hematocrit, oxygen carrying capacity, etc.), altered bone marrow function, or
a combination of both factors (see Figure 2-8). In addition, it can be
postulated tftat acute plasma volume decrements lead eventually to a normal
proportional reduction in red cell mass; however, secondary adjustments in
plasma volume occur (due possibly to the decreased red cell mass and may be in
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PREFLIGHT
INFLIGHT
POSTFLIGHT
TABLE 2-2
COMPARISON OF BLOOD DRAW PROTOCOLS
EXPERIMENTS
INS 103 - ERYTHROKINETICS
INS 105 - IMMUNE RESPONSE
IES 032 - ENDOCRINOLOGY
MEDICAL OPERATIONS
SL-1 Blood-Draw Protocol
Original Protocol
Day Blood Volume (ml )
F-30 127
F-15 123
F-ll
F-l 123
MD-2 48
MD-4 32
MD-6 71 ,
MD-8
L+0 127
L+l 80
L+7 114
L+14 84
929 ml
E
Final Protocol
Blood Volume (ml )
69
60.5
60.5
40.0
25.0
48.0
69.0
50.5
60.5
59.0
542 ml
EXPERIMENT TOTALS
78.0
64.0
250.0
50.0
542.0 ml
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TABLE 2-3
COMPARISON OF RESULTS FROM THE TWO DIFFERENT BLOOD DRAW PROTOCOLS
Results of
Protocol
MD6/MD8 Values
Hematocrit
Erythropoietin
Red Cell Mass
Red Cell Production
L+l Values
Hematocrit
Erythropoietin
Red Cell Mass
Red Cell Production
the Computer Simulati
for MD6/MD8 and L+l.
Original
With
Blood
Draws
+ 8.2
- 14.0
- 4.5
- 19.3
- 6.0
+ 2.2
- 8.8
- 18.7
Protocol
Without
Blood
Draws
+ 11
- 21.4
- 1.0
- 28.4
- 1.1
- 10.1
- 1.6
- 30.8
on of the SL-1 Blood
Results as % A Prefl
Draw
ight.
Final Protocol
With
Blood
Draws
+ 7.4
- 16.0
- 3.7
- 24.0
- 4.6
0.0
- 6.7
- 23.1
Without
Blood
Draws
9.0
- 21.0
- 2.0
- 31.0
- 1.0
- 10.0
- 2.0
- 32.0
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a direction opposite to the initial plasma volume due to the headward fluid
shift), so that the total blood volume loss is constant.
FUTURE PLANS
Based upon the work performed under the current contract, the contractor has
identified several areas of work that still need to be completed with respect
to developing/testing the hypotheses concerning overall blood volume
regulation during zero-g exposure. The major areas of work that still need to
be addressed have to do with the analysis of recent space experiments relevant
to the issue of blood volume regulation (i.e., the SL-1 experiments), analysis
of the results from the upcoming SLS-1 fluid regulation experiments, as well
as the development of a new generation of experiments specifically designed to
test some of the most promising fluid regulation hypotheses (see the
discussion of Task 3 "Design of Key Experiments Related to Body Fluid and
Blood Volume Regulation" in Section 5.0 of this report). The results of these
experiments are expected to provide a wealth of information.
Inherent to evaluating the result of the SL-1 experiments and any other
upcoming space-flight experiment related to blood volume regulation, is the
question "what impact do the experimental protocols, to be used during these
experiments, have on the actual physiological systems being measured?" In
particular, the effects of tracer injections and blood draws (both frequency
and volume of blood draws pre, in, and postflight) need to be evaluated, as
well as the effects of other experimental and non-experimental activities or
restriction such as exercise levels and durations, dietary and fluid intakes,
and any possible drug interactions. While it is beyond the scope of the
stand-alone Guyton model to study all of these possible factors, several of
these effects can be studied using this model or other models developed by
this contractor (38). Preflight, the models can be used in order to evaluate
possible interferences and either help change the proposed protocols (for
those experiments in which this contractor has played a role in developing),
or the models can be used in order to help define the most appropriate
ground-based controls for the inflight experiments. Postflight, the models
can be used to help differentiate between true space-flight results and those
results that are due to other causes.
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In summary, the majority of the future work that has been identified with
respect to blood volume regulation centers around the analysis and
interpretation of new space-flight data that has been, or will be, collected
on upcoming Shuttle missions; and the development and follow-up analyses of a
new generation of space-flight experiments designed to address the blood
volume regulation issues described in the main body of this report.
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3.0 ORTHOSTATIC INTOLERANCE AND CARDIOVASCULAR DECONDITIONING
There are two tasks In this area of physiological concern as delineated in the
Statement of Work (see Appendix A):
Task 4 - Physiological and Modeling Analysis of Cardiovascular Deconditioning
and Orthostatic Intolerance
Task 5 - Modeling Analysis of Countermeasures for Orthostatic Intolerance
A total of five technical reports (25,35,41,42,43) were prepared on the above
task areas during the contract period. The work performed is detailed in
these reports and is summarized below.
3.1 INTRODUCTION
A well-documented effect of a stay in the microgravity environment of space is
a decrement in the amount of total circulating blood volume. The loss of
blood volume appears to be the predominant factor responsible for the reduc-
*
tion in orthostatic tolerance observed following exposure to weightlessness
or related one-g conditions such as bed rest. The decrease in orthostatic
tolerance is a problem of operational concern in Shuttle flights because of
the fact that during reentry maneuvers, the crew are exposed to headward
accelerations (+G ) larger than one-g in magnitude. The combination of such
high headward g-forces and the loss blood volume can exert a powerful
influence upon cardiovascular function. In particular, circulatory pressures
and flows to the cerebral region may be reduced to such critical levels as to
seriously impact crew performance at a time when performance decrements can be
least accommodated.
There are two putative countermeasures that are used to improve the g-toler-
ance of the Shuttle crewmembers during reentry. These are: (i) pre-reentry
Factors other than decreased blood volume may be involved in the orthostatic
intolerance of zero-g. These include decreased cardiac contractility and
degraded baroreceptor responsiveness. However, no definitive findings
regarding their involvement have been made. In this report, we will
consider only blood volume as a causative factor.
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replacement of fluids and electrolytes or fluid-loading, and (il) application
of lower body positive pressure with the aid of an anti-g garment. The
beneficial effects of these two remedial measures have long been known.
However, the details of the physiological responses resulting from their use
have not been fully evaluated. Such an evaluation would require data over a
range of parameters of the counter-measures; i.e., volume and composition in
the case of fluid-load and inflation pressure in the case of anti-g suit. It
is not feasible to obtain the requisite data experimentally in an
operationally oriented environment.
3.2 APPROACH
One possible approach to study orthostatic intolerance and the effects of
fluid-loading and anti-g suit as countermeasures is to use computer
simulations of mathematical models. Such an approach was employed to provide
theoretical answers to operational questions related to Shuttle reentry. Two
different mathematical models of the circulatory system were used. One is the
Guyton model describing the long-term circulatory, fluid, and electrolyte
regulation (13). It was used to study the effects of pre-reentry replacement
of fluids and electrolytes. The basic model consisting of five vascular
compartments connected to an interstitial fluid compartment and a cellular
fluid compartment was modified to include leg vascular and tissue compartments
and gravity-dependent elements (27). The modified model has been used to
simulate water immersion (23) and head-down tilt (26), as well as to analyze
fluid-electrolyte alterations in weightlessness (24).
The second model is a short-term model of the cardiovascular system based on
the assumption of a closed vascular system with no provision for fluid
filtration into the extravascular space. The systemic circulation and the
heart are represented by a number of compartments in the model. The equations
relate the pressures and flows through lumped parameters such as resistance
and compliance of the vascular compartments. It is a beat-to-beat model valid
for simulation of events lasting less than 30 minutes. It has been used
successfully to simulate responses to exercise, lower body negative pressure
(LBNP) and tilt tests under one-g conditions (6). More recently, it has been
utilized both to reproduce tolerance to centrifugation (41) and to predict
cardiovascular responses during STS reentry (25), as summarized in Section
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Page Intentionally Left Blank
3.3.2 Cardiovascular Response During Shuttle Reentry
A theoretical study was undertaken soon after the first STS flight to evaluate
the factors that contribute to orthostatic intolerance during and following
reentry and to predict the likelihood of impaired crew performance. The
findings of this computer simulation study were presented at scientific
meetings (22,42), but the details had not been reported. Two reports (25,41)
describing the various simulations performed (using the pulsatile cardio-
vascular model) were prepared and released during this contract period.
The reports include studies on validation of the pulsatile cardiovascular
model for g-stress, studies on the effects of blood volume loss, simulations
of cardiovascular response during STS-1 reentry and crew postflight stand
tests, and predicted response of STS-2 reentry. The validation studies
involving g-tolerance indicated the need for the presence of intact autonomic
reflexes even at low levels of g-stress. This implied that with degraded
baroreceptor responsiveness following weightless exposure, which was not
assumed in the simulation studies (footnote on page 31), a further reduction
in orthostatic tolerance during reentry could result beyond that due to a loss
of blood volume alone. The results from studies on the effects of blood
volume loss showed that reentry g-forces with peaks less than 2 G would be
very well tolerated with a normal blood volume (Figure 3-1). However, these
same g-stresses, when accompanied by only moderate blood volume losses,
comparable to those that occur in space flight, might be reason for medical
concern. Furthermore, some type of impairment would become more likely, if
blood volume losses were severe, or if aspects of cardiovascular
deconditioning other than blood volume loss were present. The results were in
agreement with conclusions from early ground-based experiments, as well as
from observations of early STS flights.
3.3.3 Countermeasures for Orthostatic Intolerance (Task 5)
Fluid-loading: The influence of fluid-loading upon the time-course of changes
in cardiovascular parameters during reentry was studied with the aid of the
Guyton model of the circulatory system. Weightless conditions were simulated
by placing the model in a head-down tilt position of -6°. The STS-1 reentry
g-profile with a peak g-force of approximately 1.5 G (typical of most STS
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flights) was used to simulate reentry g-stress. The time of ingestion prior
to reentry and the salt concentration of the fluid-load were varied, while
keeping its volume constant (one liter in all simulation runs). It was not
necessary to vary the volume to understand the general behavior of the
fluid-load as this has the effect of only amplifying or attenuating the
elicited changes in physiological parameters.
The simulation results showed that the time of ingestion was not critical for
fluid-loads in which salt content was very low. Judging from the time course
of return of the cardiovascular parameters to preflight baseline levels, a
hypertonic fluid-load administered just prior to reentry had the maximum
beneficial effect in improving the orthostatic tolerance during and following
reentry (Figure 3-2). In most instances, the time-course of changes for
different salt concentrations were similar. Since the loss of fluids is not
the only causative factor behind space flight-induced cardiovascular
deconditioning compensation for fluid loss alone cannot be expected to reverse
completely the adaptive manifestations of weightless exposure.
It was plausible that the effectiveness of the fluid-load could be enhanced by
lessening the excretion of the ingested fluid. Indeed, this was found to be
true with the addition of an anti-diuretic agent to the fluid-load. In this
case, the plasma volume increase obtained at the end of the reentry period was
approximately 140 ml higher than for the corresponding situation without the
addition of an anti-diuretic agent, assuming that the action of the agent was
total, immediate, and present for the entire duration of reentry (best-case
scenario).
Anti-9 Suit: The pulsatile cardiovascular model was utilized to demonstrate
the effects of applying lower body positive pressure (anti-g suit inflation)
in order to improve g-tolerance in the face of a diminished blood volume.
Simulations were performed by varying the anti-g suit inflation pressure
during exposure to a sustained g-force of 2 G. The results clearly pointed to
the nonlinear nature of the cardiovascular system behavior (Figure 3-3).
There was a linear change in cardiovascular parameters with increase of suit
pressure up to 40 mmHg. Thereafter, the response exhibited a greater
sensitivity to suit pressure. Based on the computed systolic carotid pressure
levels, the minimum suit pressure required to avoid vision impairment
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increased with the magnitude of blood volume reduction, as one would expect.
The simulation results indicated that, for g-forces of 2 G and less, the use
of .an anti-g garment would be warranted only if the blood volume loss exceeded
10 percent.
3.4 CONCLUSIONS
The loss of fluids is not the only causative factor underlying space
flight-induced cardiovascular deconditioning. Some of the other possible
mechanisms involved include increase peripheral resistance, changes in cardiac
contractility, significant pressure/flow and compliance changes in the lower
extremities.
Blood volume loss plays a key role in the development of cardiovascular
deconditioning and the accompanying orthostatic intolerance during space
flight. Depending on the severity of loss, the reentry acceleration stress
may be detrimental to physiologic function and may place the physiologic
status of the crew near the borderline of some type of impairment.
With regard to countermeasures for orthostatic intolerance, fluid-loading is
the simplest of all from an operational standpoint. Ingestion two hours prior
to reentry would yield optimal results with minimal operational inconvenience.
Increasing the salt content of the fluid-load would enhance the beneficial
effects. Further enhancements may be achieved by the addition of an
anti-diuretic agent to the fluid-load so as to retard rapid excretion of the
ingested fluid. In the case of lower body positive pressure as a
countermeasure, the simulation results indicate a minimal pressure of
approximately 50 mmHg would provide adequate protection against vision
impairment with g-forces up to 2 G and blood volume losses up to 15 percent.
Finally, the studies demonstrate the usefulness of modeling and simulation in
addressing questions of operational interest. Future studies should include
'testing* of new countermeasure combinations as they are being suggested.
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4.0 CALCIUM REGULATION AND BONE ATROPHY
There is one task in this area of physiological concern as delineated in the
Statement of Work (see Appendix A):
Task 7 - Completion of Expanded Calcium Model and Data Base
4.1 INTRODUCTION
A mathematical model of the calcium metabolic system was developed on two
previous contracts (10,11) for the purpose of contributing to theoretical
analyses and development and testing of hypotheses related to calcium
metabolic changes which have been observed in human subjects during exposure
to hypogravic environments. Specifically, the model has been used to define
regulatory and interactive calcium metabolic events that may be occurring
within the normal, healthy physiological system during an applied experimental
stress. In this case, the applied experimental stress is a reduction in the
gravitational load to the skeletal system due to zero-g exposure.
The calcium model is a compartmental, feedback control system that utilizes
ordinary differential equations to relate passive calcium fluxes between the
major pools of the calcium metabolic system and the external environment;
specifically, the extracellular fluid, intestinal, renal, and skeletal system
(Figure 4-1). Three hormonal subsystems, parathyroid hormone, Vitamin D, and
calcitonin, actively stimulate or inhibit, via feedback control, the passive
calcium fluxes. Originally, the model was developed by Jaros, Coleman, and
Guyton (15). It was transcribed from the published report, and implemented on
a Digital Equipment Corporation VAX 11/780 (2,11).
The model has been validated with experimental bed-rest and space-flight data
and has contributed to hypotheses testing and suggesting physiological events
that may be occurring within the system (3). However, one of the main systems
of investigative interest in the area of hypogravic calcium metabolic research
is the skeletal system. Unfortunately, the main disadvantage of the model
described above is the lack of physiological representation and specificity
within the skeletal system. The model contains only a single subsystem
40
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representation of the skeletal system whose mathematical equations represent
gross estimates of the rates of calcium efflux and influx between bone, bone
fluid, and extracellular fluid compartments. As a result, the model is, and
has been, useful in developing and testing hypotheses of soft tissue changes
during hypogravic exposure, but is more limited for testing hard tissue
changes.
Jaros, Guyton, and Coleman (16) later published a report which expanded the
single skeletal subsystem representation of the calcium model into a series of
eight, physiologically representative, subsystems. In addition, the report
contained information leading to the inclusion of a phosphorus subsystem. The
addition of a phosphorus subsystem is highly desirable since reports of
bed-rest studies conducted at the U.S. Public Health Hospital in San Francisco
have suggested that supplementation of dietary phosphorus is an effective
countermeasure to the urine calcium losses recorded during bed rest and space
flight. Consequently, the skeletal and phosphorus subsystems were transcribed
and incorporated into the calcium model (2) during the previous contract
period (Figure 4-2).
Development and implementation of the expanded model during the previous
contract period did not result in a fully operational program. The model was
operational in the steady-state, but execution failed during simulations with
applied as experimental stresses. The expanded calcium model exhibited
instabilities which generally resulted in one or more variables exceeding the
output limitations. This prevented execution of the program. The main
objective of the present contract in the calcium metabolic discipline has been
to correct the instabilities during execution of the expanded calcium model
and to deliver to the customer, a model that is fully operational and
applicable to the study of calcium metabolic changes during exposure to
hypogravic environments.
4.2 APPROACH
Although the Statement of Work contains only one task in the calcium metabolic
discipline, the scope of work completed includes three subtasks. These are:
(i) to determine, and develop a technique to remove, the exact source of the
42
UJo
o
O
_J
<
o
o
UJ
Q
Q.
X
UJ
UJ
co
UJ
X
Q
£
UJ
tr
a.
O
o
ocO
C\J
I
43
numerical instabilities that occur in the expanded calcium model during
simulations; (ii) to validate the operational model with data from the
bed-rest studies conducted at the U.S. Public Health Hospital in San
Francisco; and (iii) to analyze the impact of using dietary supplements of
phosphorus and calcium as countermeasures for demineralization during bed
rest. These topics are discussed below.
4.3 RESULTS
a) Development of an operational expanded calcium model
During this contract period, extensive debugging and programming were done on
the expanded calcium model. Efforts were made to isolate and identify the
source of the instabilities early in the contract period. Three of the
skeletal subsystems whose interactions produced a positive feedback effect
were isolated as the source of the instabilities. The positive feedback
effect was eliminated by introducing damping factors into the program. This
correction resulted in a model that could run to completion, but, unfor-
tunately, developed instabilities even in the steady-state. Ultimately,
operational stability was achieved by restructuring the model as explained in
the following paragraphs.
During the previous contract period, when the model was initially implemented
on the computer, the subsystems were transcribed directly from the report of
Jaros, Guyton, and Coleman (15). In this format, the number of parameters
contained in the data base and common block exceeded the maximum number of
parameters that the main program could read and store (in excess of 300
parameters). In order to solve this problem, most of the subsystem constants
were deleted from the data base and common block and were inserted into the
appropriate subsystems to be read as internal constants. This format resulted
in a program that was executable and easy to compare with published diagrams
of the model, but difficult to debug.
As a further attempt to reduce the number of parameters and the number of
calculations of the model, all eighteen of the model subsystems were
streamlined by combining equations where possible and by replacing selected
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constants with their numerical value. Operationally, the run time of the
model improved and the magnitude of the instabilities decreased; however, they
were not eliminated.
Reducing the magnitude of the instabilities provided the opportunity to
identify the source of the remaining problems within the model such as
round-off errors on critical regulatory variables. This was corrected by
defining negligible round-off values as those values +_0.00001 from the
baseline value of the given variable. With these modifications, the
instabilities were eliminated from the model output and the model has become
fully operational. The modifications and corrections to the expanded calcium
model are recorded in an addendum to the user's guide (4).
b) Model Validation
Once the expanded calcium model became fully operational, the next step was to
validate the model through assessment of the degree of correspondence between
model output and actual experimental data by comparison of the qualitative and
quantitative trends of common variables. The objective of this type of
analysis is to demonstrate the ability of the model to reliably simulate
selected responses of the calcium metabolic system to given experimental
stresses and, thereby, gain confidence in the use of the model. During this
contract period the expanded calcium model was tested for a variety of
simulation results.
The first simulations compared model output with the published simulation
results of Jaros, Guyton, and Coleman (16). The purpose of these validation
tests was to ensure that the expanded calcium model retained the basic
characteristics of the published model from which it was derived.
Following the success of the above validation tests, simulations of calcium
metabolic changes which occur during bed rest were executed on the expanded
calcium model. These results were compared to the results of the bed rest
studies conducted at the U.S. Public Health Hospital in San Francisco
(40) and presnted in a report by Brand (5). In addition, they were compared
with results obtained using on the original calcium model (3).
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The initializing assumptions for the above simulations were the same as those
for simulations conducted on the original calcium model (3). The volume of
extracellular fluid was decreased by one liter and calcium was forced out of
the,s-bone through the manipulation of one or more skeletal variables. In the
original model the initializing loss of calcium from the skeletal was
generated through the reduction of a gravitational term. In the expanded
model, because of the improved physiological representation, several
initializing skeletal factors were examined. The bed-rest simulations were
initialized first, by decreasing the rate of bone accretion; second, by
increasing the rate of bone resorption; and third, by doing both
simultaneously.
Qualitatively, simulations initialized with any of these three initializing
options generated results similar to those of the experimental bed-rest
studies and of the bed-rest simulations with the original calcium model. The
effective decrease in skeletal calcium causes the plasma calcium concentration
to increase. As the plasma is filtered by the renal system much of the excess
calcium is passively eliminated and the system begins to return to a steady
homeostatic state. In the expanded model, however, homeostasis is not
achieved because the renal system is unable to compensate completely for the
consistent loss of calcium from the bone. Ultimately, this results in a
plasma calcium concentration that remains above the baseline value (from 5 to
9 percent) and a calcium balance that becomes increasingly negative. Within
two to three weeks of simulation time, the production rate of 1,25-dihydroxy-
vitamin D (1,25-(OH)2D) decreases which, in turn, results in a long-term
inhibition of the intestinal calcium absorption rate. With the decrease in
intestinal calcium input, the plasma calcium concentration begins to fall.
Once again, the calcium metabolic system appears to approach a homeostatic
state, but with a continual, daily loss of whole-body calcium.
Quantitative comparisons of selected maximum values derived from the
simulation and experimental data are presented in Table 4-1. The intestinal
calcium absorption rates and plasma 1,25(OH)2D concentrations are comparable
to, while the urine calcium excretion rates are significantly below, the
experimental values. Due to the variability of the experimental PTH data
(5), the PTH simulation data are difficult to assess.
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TABLE 4-1
Results of Experimental And Simulated Studies of Calcium Metabolism
During Bed Rest (percent change from baseline)
Simulation
Expanded Model
Original Model
Urine Plasma Intestinal Plasma Plasma
Excretion Calcium Absorption PTH 1,25(OH)2D
+ 10
+ 45
+ 9
+ 4
10
13
61
30
- 13
- 12
Experimental 45 0 - 18 +317 - 23
In conclusion, the simulation results demonstrate the potential of the model
to be used as a theoretical tool for analyzing calcium metabolic data obtained
from hypogravic studies. Based upon our previous experience with modeling and
simulation studies, we believe that the model will also be useful as a
theoretical tool for hypothesis testing. An example of this type of use of
the model can be demonstrated by analyzing why the calcium metabolic system
is not dramatically affected by the nature of the skeletal initialization. In
this particular case the model is structured such that the bone acts as a
buffer to the calcium concentrations in the extracellular fluid. Regardless
of whether calcium is prevented from being deposited into, or is eliminated
from the skeletal system, the impact to the extracellular fluid is the same, a
net increase in its concentration.
c) Countermeasure Studies
The final subtask to be performed in the calcium metabolic area was to
supplement the analyses of the experimental bed-rest studies with an
additional analysis of studies that investigated a select set of
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countermeasures. The countermeasures selected for analysis were those that
involve dietary manipulations of calcium and phosphorus during the bed-rest
period.
Most of the experiments designed for investigating physiological changes
during exposure to hypogravic environments involve small sample sizes.
Resource and cost considerations limit the number of subjects available for
experimental studies which, in turn, greatly limits the amount of data
obtained and the statistical "power" of the results derived. Under these
restrictions, careful analyses are essential in order to extract the maximum
amount of information with acceptable accuracy. In an effort to improve the
power of the statistical analyses and to consider the role of the experimental
protocol in these analyses, a report concerning small sample statistics
(36) was used to judge the applicability of certain statistical tests in the
Bed-Rest Analysis Software System (BRASS). BRASS is the program used to
analyze the bed-rest data.
Two of the USPHSF bed-rest studies investigated the dietary supplementation of
phosphorus and three examined the impact of simultaneous dietary calcium and
phosphorus supplementation during bed rest. None of the bed-rest studies
investigated the effect of supplemental dietary calcium apart from dietary
phosphorus. Consequently, the data analyses revolved around the influence of
dietary phosphorus supplementation with the influence of dietary calcium
supplementation assumed only if the experimental results deviated
significantly from the phosphorus results.
The statistical sample sizes of these analyses are very small. A total of 11
subjects participated in the two studies containing supplemental dietary
phosphorus protocols. Five of the subjects received a daily supplement of 83
percent of their baseline intake during specified times of the bed-rest
period. Three received their supplement during the first twelve weeks of bed
rest, while the other two received their supplement during the second twelve
weeks. Of the remaining six subjects, two received a daily phosphorus
supplement of 37 percent of their baseline intake while the two others
received 5 and the last two received 0 percent increases. Consequently, most
of the analyses are based upon the averaged results of two subjects. As a
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point of reference, the experimental results derived from these analyses are
compared to average bed-rest results established in a previous analysis of
bed-rest only data (5).
The most notable results of the bed rest and supplemental phosphorus analyses
are the effects of dietary phosphorus intake rates on the urine calcium
excretion rates. In Figure 4-3, urine calcium excretion rates (in terms of
the weekly deltas from the ambulatory average) are plotted as a function of
time for five separate bed-rest studies. Three of the studies are illustrated
in Panel A of Figure 4-3, where the subjects received 0, 5, and 37 percent
higher rates of dietary phosphorus during bed rest than during the ambulatory,
control period. Panel B of Figure 4-3 compares the results of these subjects
receiving a 0 percent increase in dietary phosphorus with the average calcium
excretion rate from the previous analyses of bed rest only data (5). The
impact of the 83 percent phosphorus supplements during selected periods of the
bed-rest phase are demonstrated in Panel C of Figure 4-3.
These results suggest that high and low doses of supplemental phosphorus
appear to exert paradoxical effects on the urine calcium excretion rate. Low
doses (less than 40 percent increase in dietary phosphorus) appear to enhance,
while high doses (greater than 83 percent) appear to inhibit the already
stimulated renal calcium excretion rates. The influence of the high dose on
the renal excretion rate is very rapid since a noticeable inhibition is
measurable within the first data collection period. In addition, the
suppression of the urine calcium excretion rate is quite dramatic; the
excretion rate decreases to a rate equivalent to or below the average rate
recorded during the ambulatory, control period.
Despite the changes in the renal calcium excretion rates, some of the other
elements in the calcium metabolic system appear to be unaffected. Significant
changes in the plasma calcium concentrations were not recorded. Changes in
the urine excretion rates of hydroxyproline, an indirect indicator of bone
resorption rates, also remained unaffected by dietary phosphorus
manipulations. In addition, most of the studies suggest that fecal calcium
excretion rates are unaffected although high phosphorus doses administered
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late in the bed-rest period may suppress average rates of fecal calcium loss.
Measurements of hormonal changes, particularly the plasma concentrations of
PTH and selected metabolites of Vitamin D were not collected.
As expected, urine and fecal phosphorus excretion rates increased as the
supplemental dietary dose of phosphorus increased. The urine excretion rates
rose by 2, 6, and 100 percent as the dietary loads increased by 5, 37, and 83
percent, respectively, above the ambulatory, control rates. Concurrently, the
fecal excretion rates increased by 20, 50, and 70 percent above ambulatory
values. The plasma phosphorus concentrations appeared to be unaffected by
dietary loads. These data simply demonstrate that the dietary phosphorus
supplements were in excess of physiological requirements and were excreted
from the body.
The above data tend to suggest that high doses of supplemental phosphorus, in
excess of 80 percent above daily baseline intake rates, may prevent the loss
of total body calcium, evidenced by negative calcium balances, which have been
recorded during exposure to hypogravic environments. Conversely, low doses of
phosphorus may promote the negative calcium balances. Unfortunately, the
mechanisms by which this suppression or enhancement may be occurring are
unclear.
Of the parameters which determine the calcium balance (assuming changes in the
sweat rates are neglibible), only the urine excretion rate appears to be
affected. This means that the calcium input rates are constant so changes in
the renal excretion rates must be obtained from or stored into an internal
calcium reservoir. The largest calcium pool in the body is the bone which
contains about 98 percent of the total body calcium. If bone resorption
increases during bed rest, as the urine hydroxyproline data suggests (5), then
the rate of resorption is unaffected by dietary phosphorus manipulations.
With high phosphorus doses, this hypothetically means that calcium is being
removed from one part of the bone and, since it is not being excreted,
probably is being stored in another part of the bone. Whether calcium is
deposited into the bone as new hydroxyapatite material, or is simply stored as
amorphous material is unclear. However, the rapidity with which the renal
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calcium excretion rate responded to changes in the dietary phosphorus loads
suggest that the calcium was stored in a readily available form and not
deposited as hydroxyapatite material.
The relationship of the calcium and phosphorus metabolic systems are not fully
understood; In an effort to theoretically clarify some of these
relationships, a simulation of bed rest and a high phosphorus diet was
executed on the model. During the simulation, the high phosphorus diet (+83
percent initialization) the phosphorus metabolic system resulted in rapidly
increasing urine phosphorus excretion rates. The plasma phosphorus
concentration rose slightly and inhibited the production rate of 1,25-(OH)2D
in the kidney. The reduction in the plasma concentration of this Vitamin D
metabolite resulted in a long-term inhibition of the intestinal calcium
absorption and thereby reduced the negative calcium balance late in the
simulated bed-rest period. Of interest, however, is the fact that the model
did not demonstrate a significant reduction in the rate of urine calcium
excretion. This is contrary to the experimental results illustrated in Panel
C of Figure 4-3 and demonstrates that the mathematical interrelationships
between the calcium and phosphorus metabolic systems within the model are not
complete.
4.4 CONCLUSIONS
The work accomplished in the calcium area during this contract period has been
very exciting. The expanded version of the calcium model, with an improved
bone system and a new phosphorus system, is fully operational. Several
simulations, aimed at testing the model responses and comparing the variable
output to actual experimental data, have been executed and have yielded
excellent results. Although the original calcium model has been useful in
testing and developing hypotheses of calcium metabolic changes during bed rest
and space flight, this model provides the detail and specificity required to
expand these analyses beyond the limits of the original model.
In the last two years a number of papers reporting the results of
investigations concerning skeletal changes in animal species during simulated
hypogravic conditions have been published. The expanded calcium model is an
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analytical tool which can be used to examine hypothetical skeletal and
metabolic implications inherent within the hypotheses. In addition, other
hypotheses may be tested. Simulation analyses provide theoretical avenues for
addressing questions involving highly interactive events within the system and
for highlighting the next series of questions to be asked. Prophylactic and
therapeutic countermeasure treatments may be proposed and assessed for
feasibility with the model prior to expending vast resources for conducting
the research. In addition, this type of simulation work can contribute to the
development of ideas for experiment proposals and experiment designs.
However, interspersed within the simulation analyses is a requirement for an
interactive relationship with experimental research programs and data. The
simulation data should be frequently tested with actual experimental data.
Other modeling techniques are available to examine the intricacies of the
model itself such as sensitivity .analyses. Sensitivity analyses define the
quantitative relationships calculated within the system, as well as the
magnitude and trend of model output generated by a change in critical
parameters. This provides the ability to conduct a detailed analysis of model'
function. The model also may be modified to represent specific animal species-
and thereby test and compare differing metabolic responses to experimental
stresses specific to human and other animal models. This is similar to the
idea implemented by Nordheim (38) for the erythropoiesis model.
In summary, mathematical modeling is a useful tool for theoretically assessing
and testing a wide variety of hypotheses specific to the system, intraspecies
differentiations, and potential countermeasures. Two promising models have
been developed and are ready for use by NASA.
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5.0 POTENTIAL CONTRIBUTIONS OF PHYSIOLOGIC MATH MODELS TO FUTURE
FLIGHT EXPERIMENTS
This section of the final report addresses Task 3 of the Statement of Work.
Task 3 states that "the contractor shall conceive, design, and test key body
fluid and blood volume regulation experiments by simulation." Since the
statement of work was issued, several key fluid/electrolyte experiments have
been conceived by NASA investigators in an effort to help design a Space
Station Life Sciences Laboratory. These candidate experiments are contained
in the NASA/JSC draft document "Human Research Facility Science Requirements
for Space Station," dated January 1985. It seemed appropriate to utilize
these as baseline experiments for this contractual task and to apply computer
simulation to help design and test them.
Each of the experiments is presented below, first by stating its title and
major hypothesis and then by a discussion of how previously developed
mathematical models could enhance the experiments. In several instances,
computer simulations were performed as examples of this application.
5.1 EXPERIMENT A: MEASUREMENT OF VENOUS PRESSURES AND PLASMA VOLUME
Hypothesis
Venous pressure decreases within a day after weightlessness is
achieved, and plasma volume decreases later. Each reaches a
level at which it is maintained for the rest of the flight.
Current fluid/electrolyte physiologic models, of which the Guyton model is
most prominent, are able to simulate changes in both central venous pressures
(CVP) and plasma volume (PV) reasonably well. It is also capable of
simulating both short and long-term events, as well as gravity-dependent
stresses. This experiment is, therefore, an ideal subject for simulation
using the Guyton model.
We simulated zero-gravity with the Guyton model by placing the "subject" in a
head-down tilt of minus six degrees after seventy-two hours of rest. Figure
5-1 shows the simulated changes in upper body central venous pressure and
plasma volume over a six month course of head-down tilt. Figure 5-2 is an
expansion of hours 50-150 and shows in detail the acute changes that take
place when the model is placed in head-down tilt at hour seventy-two.
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Placing the model in head-down tilt causes a rapid increase in central venous
(right atrial) pressure which is followed by a gradual loss of plasma volume.
The CVP then falls as plasma volume is lost and returns to baseline eight
hours after being placed in head-down tilt. The CVP continues to fall for
another twenty hours at which point both plasma volume and CVP begin to rise
again. This gradual increase in CVP and plasma volume continues for about
forty days until a new steady state is reached. Both parameters then remain
stable for the remainder of the simulated six-month flight.
This simulation can help in the design of Experiment A by identifying key data
points in the curves of the desired parameters. For instance, the model shows
CVP's maximum value to be the first data point after head down tilt is
initiated. This would imply that CVP reaches its maximum as soon as
the subject enters a zero-g environment and suggests that CVP be measured as
soon as possible after orbit is achieved. Additional graphs showing CVP as a
function of plasma volume may also be plotted in an attempt to discern a
cause-and-effect relationship.
Our simulation of Experiment A appears to give realistic data. If the actual
experimental data does verify our simulation, then we could rely on our model
to provide additional insight about parameters that were not measurable
inflight. For instance, the Guyton model could provide data points for
cardiac output and total body water and it would be possible to examine
relationships between these parameters and the verified plasma volume and CVP
parameters. Another use of the model would be to provide an extrapolation of
the verified data curves. For instance, Experiment A calls for the CVP to be
measured weekly for twelve weeks. As central venous catheter sites must be
changed at least weekly, it seems unrealistic to schedule repeated central
venous line placements on human subjects in space. The model, however, can
extrapolate the verified one week curve to twelve weeks and beyond. One or
two real data points might be collected during the twelve-week period in order
to verify the simulated data. Thus, computer models are useful not only for
providing insight into complex relationships between physiologic parameters,
but also should give realistic extrapolation of previously verified data
curves.
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5.2 EXPERIMENT B: CIRCADIAN RHYTHM OF PLASMA HORMONES AND ELECTROLYTES
DURING WEIGHTLESSNESS.
Hypothesis
Circadian rhythms change little in the space station environment,
although there is a loss of amplitude of high and low
measurements ("damping").
Although our current models do simulate ADH, angiotensin, aldosterone and the
electrolytes mentioned in this experiment, they do not attempt to simulate
circadian rhythms and thus would not be directly applicable for the purposes
of this experiment. Computer models of circadian rhythms do exist, but any
effort undertaken to incorporate a circadian system into such complex
physiologic models as Guyton's must be viewed as a major project. The problem
of simulating the light/dark and work/rest cycles aboard space station would
only complicate the matter. Nevertheless, data from inflight circadian rhythm
experiments such as the one scheduled to fly aboard Spacelab-4 may be of
significant help in designing a circadian model. There is no doubt that a
better understanding of circadian rhythms would be of great help to NASA in
scheduling crew duty cycles for long-duration missions. Physiologic modeling
can provide the necessary framework to perform a systematic analysis of the
problem in order to gain that better understanding.
5.3 EXPERIMENT C: EARLY AND LONG DURATION EFFECTS OF WEIGHTLESSNESS ON
SELECTED ENDOCRINE PARAMETERS IN PLASMA AND URINE: ANTIDIURETIC
HORMONE, HUMORAL NATRIURETIC SUBSTANCES, CORTISOL
Hypothesis
Plasma and urinary antidiuretic hormone (ADH) and cortisol
increase on the first day of weightlessness and then return to
normal or decrease. Plasma and urinary natriuretic hormone
increase later than ADH does and remain increased during
weightlessness. Rate of excretion of sodium, potassium,
chloride, calcium and phosphate vary with the time of day, but
are generally increased over preflight levels. Rate of excretion
of fluid is increased during most of the flight.
The essential design of this experiment is the measurement of several key
hormones and electrolytes every four hours during the first week in space.
The model can simulate several of these parameters. Figure 5-1 shows our
model's estimate of plasma volume over a six-month course of head-down tilt
(see Figure 5-2 for details of acute changes). Comparing these graphs with
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Figure 5-3 (change in total body water during six months of head-down tilt)
and Figure 5-4 (change in total body water during the first three days of
head-down tilt), it appears that about 40-50 percent of the loss in total body
water is due to the decrease in plasma volume. Figures 5-5 and 5-6 show the
^-responses for serum sodium concentration and the rate of renal sodium
excretion. The simulation predicts that sodium excretion rises to ten times
the baseline rate immediately after initiation of head-down tilt and remains
elevated for approximately fifteen hours. This is undoubtedly related to the
increased central venous pressure resulting from the cephalad fluid shift
which the body interprets as fluid overload. The serum sodium concentration,
however, never differs by more than 0.8 mEq/1 from its preflight (pre-tilt)
baseline. Although this may indeed be realistic, it may also represent an
excessively tight control over serum sodium concentration regulation at the
expense of urine sodium concentration and aldosterone/ADH regulation.
Other parameters shown for Experiment C include serum potassium concentration,
total extracellular potassium, and renal potassium excretion (Figure 5-7,
details of acute changes on Figure 5-8). Serum potassium concentration
initially rises, as does serum sodium concentration, probably as a result of
the decreased ADH. The low ADH level contributes to a high excretion of free
water which results in an initial elevation of all serum electrolyte
concentrations. The hyperkalemia lasts much longer than the hypernatremia,
something one would expect in an environment sensing fluid overload.
Nevertheless, the model keeps the serum potassium concentration within
physiologic limits. Total extracellular sodium, 75.2 mEq pre-tilt, finally
reaches a new steady-state of 72.2 mEq after fifty days of head-down tilt.
Six-month curves for ADH concentration and aldosterone concentration are shown
in Figures 5-9 and 5-10. Although these values have yet to be verified by
actual head-down tilt, the use of the model as a template for experimental
design is readily apparent.
While these simulations and the relationships between these variables are
basically correct, they do not all support the hypothesis given earlier for
Experiment C. For example, renal excretion of fluid and electrolytes all
return to normal in contrast to the hypothesis (and the Skylab data) which
demonstrates an increase in these factors. In contrast, a previous simulation
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study (9) demonstrated a much closer agreement with the Skylab data for renal
and endocrine measurements than was shown above. A portion of the results
from the 1977 study are shown in Figure 5-11. These results indicate
increases in fluid, sodium and potassium excretion, decreases in ADH and
increases in aldosterone and angiotensin, as predicted by the hypothesis of
Experiment C. The primary reason for this degree of accuracy was in the
assumption that total skin losses (sweat + insensible losses) were lower than
preflight. A secondary factor was the assumption of a natriuretic agent.
Both of these hypotheses were incorporated into the model prior to simulation.
5.4 EXPERIMENT D: EFFECTS OF WEIGHTLESSNESS ON ADRENAL AND KIDNEY
INTERACTION
Hypothesis
The effects of weightlessness on renal function precede its
effects on the renin-angiotensin-aldosterone system.
Norepinephrine and prostaglandin mediate some of the effects.
Major adrenal-kidney interactions include induced renin release induced by
norepinephrine (secreted by the adrenals), as well as the direct renal effects
of corticosteroids. As the Guyton model does not simulate cortisol or
norepinephrine it would not be useful for determining most adrenal-kidney
interactions without some modifications. However, it does simulate a variety
of renal parameters. Many of the desired parameters have been discussed in
the previous experiments. The two major renal parameters simulated in this
experiment are Renal Blood Flow (RBF) and Glomerular Filtration Rate (GFR).
The simulated curves for the changes in RBF and GFR during prolonged head-down
tilt are interesting (Figures 5-9 and 5-10). The RBF curve looks quite
believable, as the initial increase due to the body's central hypervolemia
gives way to sub-baseline values which are probably secondary to the
combination of a contracted intravascular volume and the direct hydrostatic
effects of a minus six degree position. The GFR curve is harder to explain
and one would have to carefully analyze the inner workings of the model to
ascertain why the GFR remains above the pre-tilt baseline despite the volume
depletion and head-down tilt. Curves for renin and angiotensin II (Figures
5-12 and 5-13) appear to respond fairly well to the various states of
hydration, although it is not clear why renin concentration achieves a
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steady-state level lower than the pre-tilt baseline while the new steady-state
level for angiotensin II is above the preflight baseline.
Although this demonstrates some of the limitations of the model as it
currently exists, it provides us an opportunity to test our current
physiologic theories about adrenal-renal interactions, the renin-angio-
tensin-aldosterone axis, and factors affecting GFR and RBF by incorporating
them into the model. The task of updating and verifying mathematical models
of physiologic systems would be simplified by using such state-of-the-art
tools as rule-based languages or symbolic programming. In addition to
updating the models to test current physiologic theories, we should also try
to get the models to simulate zero-g as accurately as possible. The models
currently attempt to simulate zero-g by simulating supine bed rest, head-down
tilt or lower body positive pressure. For instance, supine bed rest might be
currently simulated by raising mean capillary filling pressure (MCFP), which,
in turn, initiates a series of further events. A more accurate simulation of
zero-g may be accomplished by not only resetting MCFP but adjusting venous
compliance and pulmonary ventilation-perfusion mismatch as well. A new model
specifically designed for direct zero-g simulation, as well as a detailed
adrenal subroutine, may need to be developed before mathematical modeling
analysis contributes significantly to complex areas like adrenal-kidney
interactions.
5.5 EXPERIMENT E: LONG-TERM EFFECTS OF INCREASED ELECTROLYTE AND MUSCLE
LOSS ON RENAL FUNCTION
Hypothesis
Stone-forming potential of crewmembers' urine will increase with
time spent in space.
Experiment E again points out the difficulties of simulating zero-g situations
with physiologic models as they are currently configured. The important
problem of simulating the factors that may contribute to an increased risk of
kidney stone formation during space flight requires a model with strong
calcium-renal-fluid regulation interactions. At present, no model exists that
can accurately estimate the risk of renal calculi formation. Such a model
would have to accurately generate zero-g values for serum and urine calcium,
phosphate, oxalate, uric acid, pH, etc. and then be able to integrate these
factors to determine the risk of stone formation.
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5.6 EXPERIMENT F: STUDY OF CORTICOSTEROID HORMONE METABOLISM IN
WEIGHTLESSNESS BY USE OF PHARMACOL06IC INTERVENTION
Hypothesis
Weightless subjects will respond in a normal manner (increase in
production of 17-hydroxycortiscosteroids) to drugs that.-decrease
production of aldosterone and cortisol.
Experiment F is another example of an area of physiology not currently
available for computer simulation. A mathematical representation of the
hypothalamic-pituitary-adrenocortical axis could be developed, and the effects
of drugs such as metyrapone could be simulated as well. But it needs to be
emphasized that mathematical models cannot determine a priori whether or not
suppression of the hypothalamic-pituitary-adrenocortical axis occurs in space.
A certain amount of experimental data must first be gathered so that a model
may be built upon it. Only after these data have been gathered and the model
has been verified for that data can the model help investigators in
determining hidden cause and effect relationships and predicting different
outcomes under different circumstances. For instance, if a model is developed
and verified to simulate neurohypophyseal-adreno-cortical interactions on the
basis of data collected on flight days 0, 14, and 28, it will probably be .,
useful in predicting values for flight days 35 and 42. The responses of the
validated computer models may also provide new insights into the complex
relationships between multiple physiologic parameters. Furthermore, a model
would act as a repository for all of the facts, hypotheses, and inter-
relationships of these complex biological systems.
5.7 EXPERIMENT G: EFFECT OF LOWER BODY NEGATIVE PRESSURE, WATER-SALT
SUPPLEMENTS AND EXERCISE ON WEIGHTLESSNESS-INDUCED CHANGES IN ENDOCRINE
AND ELECTROLYTE PARAMETERS
Hypothesis
Exposure of subjects to lower-body negative pressure (LBNP)
prevents at least part of the increase in excretion of water and
electrolytes that usually occurs during weightlessness.
Experiment G is an ideal application for modeling. The Guyton model has been
modified by this contractor so that it can simulate LBNP and fluid loading.
The connections that exist in the Whole-Body Algorithm between the Guyton
model and the pulsatile cardiovascular model allow the user to look at both
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long-term deconditionlng as well as short-term beat-to-beat responses for a
variety of LBNP/fluid load combinations. Various degrees of exercise may also
be added to the protocol. The fidelity with which MATSCO's Whole-Body
Algorithm simulates the cardiovascular system has been illustrated (25) by a
study in which heart rate and blood pressure of the crew of STS-1 during
reentry was simulated.
Experiment G is particularly illustrative because it can be shown that
modeling is useful in designing operational countermeasure protocols in
addition to helping design experimental protocols. For instance, because the
models have been fairly well validated for reentry simulations, they would be
able to assist with the design of a fluid load/g-suit protocol to counteract
orthostatic intolerance during reentry (see Section 3.0). Rather than relying
on anecdotal data, NASA could conduct an extensive analysis by means of
simulation in order to determine the best protocol. Similarly, several
combinations of LBNP/exercise/fluid load protocols may be simulated in order
to identify those most promising for actual inflight experimentation. The
effect of these protocols on vital parameters like heart rate, blood pressure
and cardiac output could be readily obtained inflight. Model-generated
parameters could then be validated once a suitable protocol has been chosen.
Once these parameters have been validated, the model may be used to determine
which of the parameters yet to be measured inflight appear most interesting,
thus helping to design follow-up protocols. One can readily see how computer
models can be used to develop a logical series of inflight experimental
protocols, with each protocol being used to validate the model further. The
model would help identify those parameters most likely to yield valuable new
insights along each step of the way.
It is hoped that the above discussion of the seven Fluid and Electrolyte
experiments mentioned in the January 1985 draft "Human Research Facility for
Space Station IOC Science Requirements" has presented a balanced view of
physiologic models and their potential contribution to the future of NASA's
Life Science Program. We have attempted to show that models may be used to
fill in the gaps of current knowledge by simulating those parameters not
amenable to measurement inflight; that they are useful in extrapolating
long-term data from short-term experiments; that they can aid in the design of
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both one-time and sequential experimental protocols; that they can provide
valuable insights into the complex relationships between multiple physiologic
parameters; that they can systematically analyze a multitude of operational
protocols in order to determine which ones are most likely to succeed; and
finally, that they may be used as a sounding board with which investigators
may test the latest physiologic theories, especially as they relate to space
flight and the environment of zero-g.
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APPENDIX C
BIOMEDICAL PROBLEMS
GENERAL ISSUES
ADAPTATION TO ZERO-G '
Assess the mechanisms involved during adaptation to weightlessness in the
different physiological systems of the body.
PHYSIOLOGICAL LIMITS
Determine the limits of stay in space by assessing the time course and end
points of processes involved in identified biomedical symptoms.
MULTIPLE EXPOSURES
Study the effects of repeated short-term exposures to space flight on
specific physiological systems or psychological behavior with regard to
measuring the relaxation time of these effects following flight,
determining if the effects.are cumulative, and assessing the optimal
periods between flight exposures.
COUNTERMEASURES
Determine the countermeasures to biomedical problem areas that limit man's
productivity and safety.
READAPTATION
Determine the processes of readaptation to Earth's gravity and discover
methods to minimize adverse aspects of this condition.
CREW HEALTH
Determine the optimal training and physiological conditioning regimes that
would maintain crew health during inflight exposure to zero-g and
readaptation to one-g. These include considerations of exercise, diet,
drug administration, biofeedback, or other mental exercise.
INDIVIDUAL VARIABILITY
Determine how weightlessness affects various types of individuals with
special consideration given to factors such as age, gender, and physical
condition.
ANIMAL MODELS
Develop appropriate animal models for conducting studies related to
biomedical problems.
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GROUND-BASED ANALOGS
Utilize space- flight experiments to verify hypothesis developed through
ground-based analogs.
EQUIPMENT AND METHODS
Utilize state-of-the-art equipment and techniques to reliably perform
critical measurements (primarily non-invasive) reflecting the adaptation
processes in the context of testing and verifying a scientifically sound
hypothesis.
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HUMAN SUPPORT
MEDICAL SUPPORT AREA
Monitoring Diagnosis and Treatment
o Develop and evaluate biomedical monitoring and testing procedures for
space flight application which would provide significant information
regarding the flight crew's medical status.
o Develop clinical laboratory procedures, including analyses of
biological fluids (blood/urine), which could be used under weightless
conditions for routine biomedical evaluation and testing.
o Develop diagnostic imaging equipment that operates in a gravity-free
environment and which addresses a known biomedical problem developing
from the adaptation process or some trauma/illness situation.
o Determine if the incidence, treatment, and healing of trauma in
weightlessness is identical to that in one-g.
o Study the underlying basis of various medical treatments that have
unique problems associated with them due to the weightless
environment. Examples of such procedures include pharmacokinetic
studies, wound, burn and fracture healing, fluid therapies, and
responses to bleeding and clotting.
o Determine if the pharmacokinetic processes (drug absorption,
transport, metabolism, efficacy, excretion) of drugs administered in
space are the same as those administered in one-g.
o Study the effect of exercise on crew performance.
o Study the effect of altered sleep/work cycles on crew performance.
o Develop standards of normal crew health for the weightlessness
environment.
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BIOMEDICAL PROBLEMS
HUMAN FACTORS
CRITICAL ISSUES
Continued development of self-regulatory, health maintenance
procedures, such as self monitoring of physiological health
indicators, prescribed drug and exercise treatments, and biofeedback
techniques, to contribute to the individual's physical and
psychological adaptation to the space environment (for example, using
biofeedback techniques to reduce or prevent symptoms of space motion
sickness).
Determination of the relationship of tasks performed on Earth and
those performed in space, in terms of time, energy, manpower, etc.,
to define optimal workloads and work schedules in the space
environment.
Further development of procedures and techniques to predict and
select individuals most adaptable to the zero-gravity environment, to
the social and physical confinement and isolation of habitablity in
space, and to the work to be performed both as an individual and as a
group member under space-flight conditions for extended durations.
Further development of procedures and techniques to optimally train,
on Earth, individuals and groups to perform tasks proficiently and
efficiently in the zero-gravity environment. This includes training
manual dexterity, physical coordination, and muscular strength to
each individual and physical orientation and coordination between two
or more individuals to perform tasks that demand specific, acquired,
zero-gravity skills.
Investigation of optimal spacecraft design to help individuals to
adapt to the confined, isolated, and weightless environment of space
flight and to provide leisure facilities for both recreation and
privacy.
Investigation of spacecraft design as a tool to amend, or improve,
task performances that are impacted by losses of sensory and
perceptual discrimination in the space environment (such as depth
perception in the presence of a black background, applying leverage
in the absence of gravitational forces, and estimating the amount of
force necessary to move an object from one location to another).
Development of a social and governmental structure to provide
organizational and regulatory support to a group of individuals
living in the confined and isolated environment of space for extended
periods of time.
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GENERAL PHYSIOLOGICAL AND BEHAVIORAL ISSUES
o Definition of behaviors that are required to productively perform and
live in space, promotion and maintenance of their occurrence within
individual variability.
o Development of a fundamental understanding of behavioral variability
within individuals and creation of a data base containing complex
behavioral and performance data.
o Investigation of changes in perceptual functions (such as auditory
localization, depth perception, body weight as a force,.etc.),
sensory sensitivity (threshold changes in color discriminations,
tactile sensation, auditory levels, etc.), and sensory-motor
interactions as they effect learning, adaptation, and discrimination
in the space environment.
o Determination of the relationship of biological rhythms, behavior,
and performance.
o Determination of how an individual's social and non-social
environment influences his or her behavior so that performance and
health of the individual may be maximized.
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LIFE SUPPORT SYSTEM
Biochemical and Plant Studies
The following issues are listed in an order that approximates an increasing
complexity of chemical and biological participation in a life support system.
The ranking does not imply research priorities. In fact, investigations into
any of the systems would provide highly important data for the development of
life support systems destined for long-term, orbiting space flight. These
issues denote areas of study that could be investigated in a two-week or short-
term space flight. Other questions regarding basic plant physiology, such as
nutrient uptake studies, are considered in the section on Gravitational
Biology.
o Investigation of photochemical and chemical systems in zero-g, in
order to demonstrate photocatalytic and photoelectrochemical
conversion of HpO to H2 and Oy.
o Investigation of the processes of non-photosynthetic microbial food
production (such as methylotrophic yeasts) using chemically
synthesized substrates or those available in the waste stream.
o Study of the life supporting processes of 0« production, COp removal,
and nitrogen cycle closure in a microbial, photochemical ly active
system in zero-g, such as that provided by filamentous blue-green,
nitrogen-fixing algae.
o Evaluation of sensitivity of microbial cultures, such as algae, to
changes in environmental parameters in zero-g, such as the amounts of
Op and C02, the intensity and frequency of light, and amount of
nitrogen fn the media.
o Evaluation of the potential of hardy, cosmopolitan, edible plant
species, such as onion, tomato, and lettuce, for use as food in a
life support system in zero-g. In particular, characterization of
their baseline plant growth kinetics in zero-g and determination of
the conditions under which their growth is optimized.
o Development of efficient means of growing higher plant biomass in
zero-g, through such means as hydroponics. Are there advantages to
propagating plants from tissue culture as opposed to seeds, in
weightlessness?
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System Studies
The following issues concern the design and development of waste management
and food production systems in a weightless environment. Many of these issues
are engineering problems which require the collaborative effort of biologists,
chemists, and materials scientists.
o Development of fluid handling and gas-liquid interchange methods for
algal cultures and waste management systems in zero-g.
o Development of a method for direct sunlight illumination of plant and
algal growth chambers, in an orbiting spacecraft.
o Management of transporting nutrients to the plants' root systems. In
particular, design and verification of a water handling scheme in
zero-g to bring in nutrients and carry off waste and excess
materials. Follow-up of proven ground-based system designs by flying
larger scale versions.
o Study of the feasibility of using aerobic digestion and direct
oxidation to convert organic wastes (such as cellulosic plant
material, kitchen wastes, wash water, urine, and feces) to CO^ and
HpO in zero-g.
o Study of the feasibility of using an algal growth chamber in a closed
environmental life support system for space station, by flying a
large scale algal growth system on an STS mission.
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BIOMEDICAL PROBLEMS
CARDIOVASCULAR AND CARDIOPULMONARY AREA
CARDIOVASCULAR DECONDITIONING
o .- In-depth assessment of cardiovascular function both at rest and
during stress tests using a variety of measurements at various stages
of the space mission, immediately following weightlessness and
continuing through the postflight phase. Included in this
investigation is the development of improved non-invasive techniques
to provide accurate and reliable hemodynamic measurements in humans
under space flight conditions.
o Determination of the relative contributions of blood volume loss and
autonomic function changes in zero-g toward orthostatic intolerance.
o Determination of the degree of cardiovascular deconditioning and its
correlates with physiologic and other factors (environmental and
behavioral) through a detailed analysis of inflight and postflight
cardiovascular responses.
o Prediction of susceptibility to orthostatic intolerance in the
presence of space flight induced cardiovascular deconditioning.
o Evaluation of changes in cerebral hemodynamics during reentry to
assess the severity of orthostatic intolerance.
o Study of the effect of repeated short-term exposures to zero-g on the
time-course required for the space-flight induced cardiovascular
changes to return to normal.
COUNTERMEASURES
o Further development and testing of the existing types of counter-
measures to cardiovascular deconditioning to confirm their effective-
ness and to refine their patterns and means of use. Examples of
putative measures are fluid and salt repletion, anti-g garments,
lower body negative pressure, and physical exercise.
o Formulation of experiments to test the utility of drugs and hormones
as prophylactic or therapeutic countermeasures to orthostatic
intolerance.
o Clarification of the beneficial role of physical exercise during
space flight.
o Evaluation of the use of positive pressure breathing in conjunction
with anti-g suit during reentry.
o Development of alternate means to lower body negative pressure for
stressing the vascular system of the lower extremities during
weightlessness.
o Development of measures to improve the reversal of space-flight
induced cardiovascular changes following return to Earth.
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INTERDISCIPLINARY ISSUES
o Studies on decompression sickness and nitrogen washout.
o Clarification of the relationships between cardiovascular and
cardiopulmonary responses and changes in blood volume, red cell mass,
and body fluid composition during weightlessness.
o Study of the effect of changes in levels of circulating and excreted
hormones on cardiovascular function.
o Assessment of the degree of attenuation or exaggeration of cardio-
vascular response to zero-g by nausea and dehydration attendant to
space sickness.
o Direct determination of basal metabolic rates during weightlessness.
o Assessment of the role of muscle atrophy in altered exercise capacity
seen in zero-g.
o Determination of the relative importance of physical inactivity due
to both personal protective equipment and confined space environment
versus weightless exposure in the induction of cardiovascular
deconditioning.
o Development of appropriate animal models suitable for studying the
cardiovascular deconditioning process in weightlessness.
GENERAL PHYSIOLOGY
o Elucidation of the effects of weightlessness on local regulatory
mechanisms of the cardiovascular system through determination of
absolute changes in venous capacity and venous compliance.
o Characterization of the time-course of changes in central venous
pressure and demonstration of the presence or absence of Gauer-Henry
reflex.
o Evaluation of the role low-pressure baroreceptor function in
cardiovascular adaptation in zero-g.
o Study of the influence of organ blood flow redistribution (renal,
cerebral, lower-extremities) on cardiovascular adaptation to zero-g.
o Study of cardiopulmonary adaptation in zero-g using measurements at
rest and during exercise at various levels including the maximum.
o Assessment of respiratory function changes in zero-g including
changes in pulmonary blood flow distribution and blood gas tensions.
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BIOMEDICAL PROBLEMS
BODY FLUIDS AND ELECTROLYTES
MAJOR PROBLEM AREA: LOSS OF BODY FLUIDS
o Identification of mechanisms leading to acute loss of fluid and
electrolytes, including characterization of headward fluid shifts,
central hypervolemia, compartmental fluid volume changes, renal
alterations leading to urine formation, alteration of plasma
biochemistry, endocrine behavior related to fluid-electrolyte
regulation, and associated circulatory disturbances. Utilize serial
measurements where possible to characterize dynamic responses.
o Identification of mechanisms affecting readaptation of fluids and
electrolytes to terrestrial conditions upon return to one-g.
o Assess fluid regulatory response and renal function using provocative
testing such as fluid/salt loading, venesection, lower body negative
(or positive) pressure.
o During the more prolonged periods of space flight (the adaptive
period following acute changes) clarify the hormonal, hemodynamic,
and autonomic mechanisms which regulate fluid and electrolyte levels
and determine whether the fluid volume and electrolyte losses become
more or less severe.
o Distinguish between volume and osmoregulation in the control of renal
function during space flight.
o Determine the factors which generate the changing plasma levels of
the major hormones and electrolytes during adaptation to zero-g
(major electrolytes: sodium, potassium, calcium, magnesium,
chloride, phosphate; major hormones: ADH, aldosterone, angiotensin,
renin, prolactin, prostaglandins, natriuretic factor, cortisol).
o Determine the causes and consequences of the persistently elevated
sodium and potassium urinary excretion levels previously observed in
astronauts.
o Determine if the non-renal quantities involved in metabolic balance
of fluids and salts (i.e. thirst and diet, sweat, feces) are
fundamentally disturbed in weightlessness.
o Determine the effects of ancilliary factors on the basic fluid
responses to weightlessness, including the influence of fluid intake,
dietary constituents, physical condition, gender, age, activity
levels, and prophylactic drugs.
o Collect the necessary data to validate ground-based analogs such as
water immersion, lower body positive pressure, and head-down tilt, as
appropriate maneuvers to investigate zero-g phenomena.
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o Development of appropriate animal models for conducting invasive
studies in space and studying issues related to fluid-electrolyte
biomedical problems.
o Assessment of the increased risk of kidney stones during weightless-
ness, -due to elevated serum calcium, and the effect of diet on this
risk.
o Determine if the adverse affects of body fluid losses (mostly
encountered upon return to Earth) can be counteracted by such
measures as fluid infusions, anti-diuretic agents, or inflight lower
body negative pressure.
INTERDISCIPLINARY ISSUES
o The contributory role of body fluid losses to orthostatic intolerance
in general, and to the stresses of reentry and recovery in particular.
o Possible contribution of central vascular congestion to motion
sickness.
o Determination if central hypervolemia is self-correcting or if its
persistance could lead to impaired heart function.
o Determine the role of the kidneys on calcium loss during space flight.
GENERAL PHYSIOLOGY
o Characterization of the circadian patterns of fluids, electrolytes,
and hormones during flight, with emphasis on determining if weight-
lessness produces a shift in these rhythms, and if so, what are their
consequences.
o Determination of the distribution of substances in various body
compartments following entry into space.
o Determine whether acid-base regulation is disturbed in weightlessness
and if it plays a significant role in the adaptation process.
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BIOMEDICAL PROBLEMS
VESTIBULAR
SPACE SICKNESS
o Ascertain which factors are responsible for space sickness suscepti-
bility. What is the source of tolerance in a resistant individual?
o Determine whether an association between the symptomatology and time
course of the space sickness disorder and physiological/environmental
parameters can be documented.
o Evaluate the currently conceived models of space sickness (i.e.
sensory conflict, overstimulation of the vestibular end organ,
labyrinth fluid inbalance).
o Assess the contribution of neuronal reflexes and organ systems, other
than the vestibular system, in producing the space sickness disorder.
o Distinguish between the roles of weightlessness and head and body
movements in contributing to the symptoms of space sickness.
o Determine the relationship between sensory disturbances that provoke
one-g motion sickness.and the causal mechanisms of zero-g space
sickness.
o Can animal models provide measurable responses to low gravity and
motion stimuli and serve as useful indicators of human responses?
COUNTERMEASURES
o Is there a one-g maneuver for producing sensory disturbances
analogous to those that provoke zero-g space sickness? Could this
method be used for ground-based research, crew selection, and crew
training?
o Determine methods for enhancing parabolic flight-induced
weightlessness as an analog to orbital flight and for studying
resistance and susceptibility to space sickness.
o Can efferent input into the vestibular apparatus and otoliths be
manipulated in a manner that will tune out the mismatched sensory
input?
o Develop training programs that will prevent the occurrence of space
motion sickness. Determine if training must be time-intensive
(single sessions) or repetitive (multiple sessions) in nature.
o Assess whether preflight habituation to motion sickness can be used
to hasten inflight habituation and to ameliorate or prevent space
sickness. What other measures can be taken to accelerate adaptation?
Distinguish between habituation and adaptation.
o Develop methods to reduce the severity of symptoms developed inflight.
o Assess the efficacy of drug intervention for preventing or
suppressing space sickness. Compare drug effectiveness in zero-g
with that in one-g.
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INTERDISCIPLINARY ISSUES
Determine if changes in labyrinthine function during space flight can
be attributed to the efects of fluid shifts (or other circulatory
factors) occurring, for example, in the endolymph, cerebral spinal
fluid, and vasculature.
Assess whether the known processes of negative calcium balance and
bone demineralization wjjiich occur in zero-g affect otolith function.
What is the role of Ca in hair cell receptor potentials?
Evaluate the effect on the sensory input of deconditioned muscles
belonging to the postural reflex arc.
Evaluate the effect of crew space sickness on workload, performance,
crew behavior, and habitability.
Determine whether certain areas of the brain, such as the brain stem,
cerebrum, cerebral cortex, diencephalon, and cerebellar regions, are
critical to the development of space sickness, and correlate neuronal
responses from these regions with those emanating from the vestibular
region.
GENERAL PHYSIOLOGY
Characterize the development of the graviceptor systems and postural
reflexes in weightlessness.
Determine the mechanisms by which space and gravity are perceived and
integrated across sensory modalities to make normal postural and
motion possible on Earth and in space.
Assess whether the vestibular system remains physiologically normal
during space flight, such that key neuronal circuits and reflex
pathways, neurochemical transmitter mechanisms, and anatomical
components respond in zero-g as they would to stimuli in one-g.
Determine whether morphological changes in otoconial, labyrinthine,
or neuroepithelial structures are associated with exposure to zero-g.
Evaluate the responses of the vestibular system in zero-g with
respect to the roles of age, gender, and physical condition.
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BIOMEDICAL PROBLEMS
HEMATOLOGY/IMMUNOLOGY
HEMATOLOGY
LOSS OF RED CELL MASS
o Characterization/verification of the time course and magnitude of
changes that occur in the erythropoietic system during exposure to
zero-gravity including changes in: total blood volume, plasma
volume, red cell production, red cell destruction, as well as changes
in erythropoietin concentration and other controlling factors of
erythropoiesis.
o Determine if the observed decrease in red cell mass is: a normal
zero-g adaptation process (self limiting), a transient response (self-
correcting) to changes brought about by various flight related
stresses, or a fundamental impairment of the red blood cell
proliferation system.
o Determine to what extent the observed decrease in circulating red
cell mass is due to a decrease in production as opposed to an
increase in destruction, and identify the underlying mechanism(s)
responsible, including the assessment of factors such as: random
hemolysis, erythrocyte shape changes, and membrane fragility that
might cause an increased red cell destruction; or plasma volume
shifts/hemoconcentration, changes in erythropoietin concentration,
erythropoietin inhibitors, oxygen-hemoglobin affinity, blood flow,
nutritional influences (diet, dehydration, space sickness) on bone
marrow red cell production, ineffective erythropoiesis, or a altered
sensitivity of marrow to erythropoietin which might cause a decrease
in red cell production.
o Identify the mechanisms affecting the readaptation of the red cell
system to a one-g environment, including: the characterization of
the time course of readaptation, the reversibility of inflight
changes upon return to one-g and whether the repeated exposure of a
subject to zero-g poses any potential health hazards.
GENERAL PHYSIOLOGICAL ISSUES
o Evaluate the use of animal models (rodent, primate, or other small
mammals) for extensive and invasive studies of human erythropoiesis
control during space flight.
o Determine if the stress of space flight alters the ability of the
hematological system to respond to erythroid stresses such as hypoxia
and venesection.
o Determine what effects diet, stress, and weightlessness per se have
on red cell proliferation.
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o Identify other red cell changes that take place during space flight
(such as changes in morphology, function, metabolism, membrane
characteristics and fragility) and the underlying causes and
consequences of those changes.
o Determine if the body's hemostatic mechanisms are altered during
exposure to space flight, including: changes in platelet function,
morphology, and kinetics and the relationship of platelets to bubble
formation during decompression sickness.
INTERDISCI PL INARY/COUNTERMEASURES
o Investigate the role that increased bone demineralization plays in
the observed decrease in red cell mass including erythrosuppression
due to such factors as: altered bone marrow function, calcium
induced hormonal changes, and changes in local cellular factors that
control hemopoiesis.
o Determine if there is a relationship between space flight induced
changes in red cell mass and space-flight changes in either protein
or energy metabolism.
o Determine the relationship between space-flight changes in non-
erythropoietic hormones (such as calcium regulatory hormones, stress-
related hormones, and growth or metabolic regulatory hormones) and
changes that occur in the erythropoietic system.
o Evaluate the affect of space flight induced alterations in the
erythropoiesis system on human exercise performance (cardiopulmonary)
during or after space flight and orthostatic intolerance postflight.
o Determine the effectiveness of infusing red cells and/or plasma on
reentry to provide either temporary or permanent relief for
postflight orthostatic intolerance.
o Evaluate the need for countermeasures to compensate for the decreased
red cell mass and/or plasma volume.
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BIOMEDICAL PROBLEMS
HEMATOLOGY/IMMUNOLOGY
IMMUNOLOGY
IMPAIRED IMMUNE RESPONSE
o Determine the nature of the effect of space flight on innate and
acquired immunity including: characterization of the time course and
magnitude of changes that occur in differential leukocyte counts and
immunoglobin concentrations.
o Determine if space flight produces a functional impairment in the
ability of the immune system to respond to specific challenges
including: changes in leukocyte function (chemotaxis, adherence, and
phagocytic abilities), bone marrow leukocyte production, and B- and
T-lymphocyte response to mitogenic challenges.
o Identify the underlying mechanisms that are responsible for any
observed space-flight.related changes in the immune system including:
alterations in cell proliferation due to weightlessness per se, or
other stresses via hormonal and/or cellular mediators.
o Determine if the effects of space flight on the immune system are
completely reversible upon return to one-g, or if repeated space-
flight exposures will produce cumulative effects that might
compromise crew health in space or after return to one-g.
GENERAL PHYSIOLOGICAL ISSUES/INTERDISCIPLINARY ISSUES
o Determine the effect that stresses other than weightlessness (diet,
space sickness, launch reentry, EVA's, etc.) have on the
immunological system including: studies of the kinetics of
lymphocyte proliferation in weightlessness, the effects that varying
gravitational environments have on lymphocytes, and the relationship
of stress related hormones (corticosteroids, catecholamines, etc.)
have on lymphocyte function and proliferation.
o Evaluate which animal models of the immune system are appropriate for
studying human immunological changes during space flight.
o Determine if decreased bone demineralization has any effect on
leukocyte proliferation inflight or postflight.
C-16
IMMUNOLOGY
ASSUMPTIONS
o While no major changes have been shown to take place in the human
immune system during or as a result of space flight, there have been
a sufficient number of smaller immunological changes have taken place
during zero-g to warrant a closer look into all areas of
immunocompetence during space flight. However, at this point in
time, these studies are probably of lessor importance than some of
the issues in the other biomedical problem areas.
o Work that needs to be done in this area includes: 1) identifying
and/or documenting changes in the system: a) without secondary
stresses and, b) under secondary stresses such as specific mitogenic
challenges, 2) identification of the underlying mechanisms involved
in any change, and 3) assessing the reversibility of any change after
return to one-g.
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BIOMEDICAL PROBLEMS
BONE/CALCIUM
BONE DEGRADATION
Characterization of the hormonal, renal, intestinal, and skeletal
mechanisms that regulate plasma calcium levels and result in a whole-
body loss of calcium during adaptation to zero gravity.
Determination of the factors that regulate the changing plasma levels
of major electrolytes (calcium, phosphorus, and magnesium) and
hormones (parathyroid hormone, calcitonin, and vitamin D) during
adaptation to zero gravity.
Study of mechanisms leading to the ultimate degradation of bone,
including characterization of the effects of changes in mechanical
(tensile, congressional, shearing, and torsional) stresses, localized
plasma volumes, and bone cell (osteoclastic, osteoblastic, and
osteocytic) activity rates upon entry into zero gravity.
Identification of the major sources, such as muscle tissue, bone
fluid, and/or hydroxyapatite, and sites of the whole-body calcium
losses upon exposure to a zero-gravity environment.
Characterization of the effects of repeated space-flight exposure on
bone and calcium regulation.
Characterization of the nature of change in bone and calcium
metabolism upon return to Earth.
Characterization of the changes in bone density, strength, and
cellular (osteoclastic, osteoblastic, and osteocytic) activity rates
as inflight duration increases.
Determination of the causes and effects of the persistently elevated
urine calcium excretion rates observed in the crewmembers of previous
space-flight missions.
Evaluation of the influence of additional factors, such as age,
gender, physical conditioning, exercise, dietary constituents, and
drugs on the skeletal and calcium metabolic responses to
weightlessness.
Study of provocative tests, such as calcium, phosphorus, and hormone
infusions during zero-gravity to assess the efficiency of the calcium
regulatory system in spite of the adaptative skeletal and calcium
metabolic changes.
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COUNTERMEASURES
o Development of prophylactic and therapeutic countermeasure treatments
to reduce or prevent the skeletal and whole-body loss of calcium
during space flight.
o Evaluation of phosphorus supplementation as a prophylactic and
therapeutic countermeasure treatment for the skeletal and whole-body
losses of calcium during space flight.
GENERAL PHYSIOLOGICAL ISSUES
o Evaluation of animal models which are best suited for the study of
human bone and calcium metabolism in zero gravity.
o Characterization of the nature of the effect of space flight on
phosphorus and magnesium metabolism and their relationships to the
calcium metabolic changes.
o Study of the acid-base balance during space flight and its influence
on bone and calcium metablic changes during space flight.
o Study of neonatal and fetal bone development in a weightless
envi ronment.
o Investigation of changes in the urine excretion rates of
hydroxyproline as a reliable indicator of changes in bone resorption
rates during space flight.
INTERDISCIPLINARY ISSUES
o Characterization of the relationship of muscle atrophy and bone
degradation during space flight.
o Study of the influence of steroid (estrogen, glucocorticoids,
prostaglandins, etc.) and general (growth hormone, insulin, thyroxin,
etc.) hormones on bone metabolic changes during zero gravity.
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BIOMEDICAL PROBLEMS
MUSCLE
MUSCLE ATROPHY
o Determination of mechanisms, such as disuse, dietary deficiency, and
alterations in glucose or protein metabolism, which are responsible
for the decreases in muscle mass and strength during space flight.
o Characterization of the changes in muscle cells and tissues in terms
of structure, biochemistry, EMG, and strength during zero-gravity
exposure.
o Evaluation of the fast versus slow muscle tissues and postural versus
non-postural muscle groups that are effected during space flight.
o Determination of the relationship of dietary protein, protein
metabolism, and muscle mass loss during space flight.
o Evaluation of the relationship of caloric intake, energy expenditure,
and muscle mass loss during space flight.
o Characterization of the influence of physical conditioning, gender,
and age on the losses of muscle mass and strength during space flight.
o Evaluation of multiple exposures to zero-g on muscle tissue changes.
CQUNTERMEASURES
o Development of prophylactic and therapeutic counter-measure treatments
such as exercise, caloric intake, and protein intake to prevent or
reverse skeletal muscle alterations during space flight.
o Evaluation of hormonal and other pharmacological treatments as
effective means to reduce or prevent muscle atrophy during space
flight.
GENERAL PHYSIOLOGICAL ISSUES
o Evaluation of animal models which are best suited for the study of
changes that occur in human muscles during space flight.
o Study of cellular protein metabolic changes of muscle during space
flight, including protein synthesis and breakdown and ami no-acid
pools and turnover rates.
o Determination of time course and adaptive limits that occur during
space flight if no countermeasures are applied.
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Study of cellular changes in energy metabolism of muscle during space
flight, including carbohydrate and lipid metabolism, and ATP
production and utilization.
Comparison of the changes in muscle integrity, such as structure,
strength, EMG, and biochemistry during space flight, disuse,.-
starvation, and denervation.
INTERDISCIPLINARY ISSUES
Study of whole-body protein metabolism, including nitrogen balances,
amino-acid pools and turnover rates, muscle catabolism, and dietary
requirements, and its relationship to muscle loss during space flight,
Study of changes in whole-body carbohydrate and lipid metablism such
as energy expenditure, caloric intake, and glucose tolerance, and
muscle atrophy during space flight.
Determination of the effect of endocrine (growth hormone, insulin,
glucagon, testosterone, etc.) changes on muscle metabolic changes
during space flight. -
Evaluation of the influence of circulatory changes, such as headward
fluid shifts, decreases in red blood cell mass, capillary volume, and
oxygen delivery, etc., on changes in muscle mass during space flight.
Evaluate the relationship between zero-g muscle atrophy and fatigue.
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BIOMEDICAL PROBLEMS
METABOLISM
CRITICAL ISSUES
Energy Regulation
Determine if the components of energy balance are altered during
exposure to zero-g under carefully controlled nutritional conditions
with accurate measurements of food and water consumption, activity,
oxygen consumption, and carbon dioxide production. Is basal
metabolism altered during zero-g? In particular, are the amounts of
energy substrates metabolized appropriate to the energy demands in
zero-g, or is metabolic efficiency altered?
Determine energy expenditure during both isotonic and isometric
exercise in zero-g using measurements such as gross body composition,
oxygen consumption and respiratory quotients, or turnover rates of
body water to measure energy and material balance. To what extent
does the body utilize carbohydrates versus fats as substrates for
energy production during exercise?
Studies of glucose metabolism during weightlessness including
characterization of insulin levels and production, free fatty acid
and triglyceride levels, and other factors of carbohydrate and fat
metabolism.
Elucidate the mechanisms involved in the observed sub-normal levels
of plasma glucose and insulin under fasting conditions in zero-g. In
particular, is the low glucose concentration due to increased
peripheral utilization or decreased hepatic release of glucose?
Assess if ATP is generated from substrates and utilized during
exposure to zero gravity with the same efficiency as during exposure
to one-gravity.
Assess if the extraction and storage of the substrates glucose, non-
esterified fatty acids, lactate, and amino-acids by the tissues of
the body occur at normal rates.
Determine if anabolic and catabolic responses associated with energy
and substrate mobilization function normally at zero gravity.
Evaluate the ability of energy regulating mechanisms to readjust to
one-g conditions when required.
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Protein Metabolism
o Define and/or validate the changes that occur in protein metabolism
during weightlessness including measurements of total body protein,
nitrogen balance, as well as plasma concentrations and turnover rates
of individual amino-acids.
o Identify the mechanism(s) by which zero gravity alters body protein
metabolism. In particular, is the negative nitrogen balance due to
reduced protein synthesis or enhanced protein degradation?
o Evaluate whether the negative nitrogen balance represents a zero-
gravity adaptive phenomenon, or whether the negative balance
represents a fundamental impairment of the nitrogen-accretive process.
Endocrine Changes
o Characterize the "normal" endocrine response to weightlessness and
space-flight stresses unrelated to gravity and determine how these
responses affect the regulation of energy balance by hormones such as
insulin, glucagon, thyroxine, cortisol, catecholamines and pituitary
growth hormone.
o Determine if inappropriate metabolic responses are due to altered
hormone levels or from alterations in hormone receptors.
o Determine the role of hormones (growth hormone, cortisol, etc.) and
secondary hormonal mediators (for example, somatomedins) in the
development of the negative nitrogen balance in microgravity.
GENERAL PHYSIOLOGICAL ISSUES/COUNTERMEASURES/INTERDISCIPLINARY ISSUES
o Evaluate methods to minimize the negative nitrogen balance including
measures such as changes in nitrogen (and/or energy intake),
exercise, hormonal treatment (testosterone and pituitary growth
hormone).
o Identification of appropriate animal models of human energy balance
and protein metabolism in order to perform more extensive and
invasive metabolic studies.
o Determine the minimal gravity force required to maintain normal body
nitrogen metabolism.
o Determine if muscle degradation is due to a fundamental change in
protein metabolism rather than muscle disuse atrophy.
o Determine the relationship between altered muscle and bone metabolism
and space-flight changes in metabolic related hormones such as the
pituitary growth hormone, cortisol, and others.
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Evaluate the relationship between an altered metabolic demand and the
observed flight decrease in red cell mass.
Assess disturbances in circadian rhythms in metabolic and hormonal
systems during space flight, including an evaluation of
characteristics of normal space-flight circadian rhythms. In
particular, determine if there is a shift in the normal metabolic
rhythms, an entrainment of a new work/rest cycle, or changes that
could affect other physiological studies.
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BIOMEDICAL PROBLEMS
RADIATION
Perform dose-response studies during space flight taking into account
the types of radiation involved in exposure - low or high LET
(Linear Energy Transfer)
dose - low, medium, or high; single versus fractionated.
early, intermediate, and late biological effects - biochemical,
cellular, and histologic changes; alterations in genetic
material and in specific organs of special importance (the brain
and the retina, for example); effects on life span of cells and
animals.
Morphologic studies in animals to determine the extent of tissue
damage resulting from exposure to radiation in space. Assessment of
observed morphologic changes to determine if they have, any functional
significance in terms of organ dysfunction and/or decrement in
performance.
Detection of functional changes using neurophysiological and
behavioral testing techniques following radiation exposure in space.
Studies to determine possible synergistic, additive, or antagonistic
effects of combining different types of space radiation with zero-g
and other stress factors associated with space flight. Examples of
such studies include evaluation of possible problems in cell prolif-
eration kinetics under the combined (stresses of radiation and
weightlessness, and studies of animal responses to combined)
radiation and centrifugation in space, employing well-defined onboard
radiation source.
Investigation of the biological effects of protracted and/or repeated
exposures to HZ£ particles in space.
Development of information and techniques for determining relative
susceptibility of humans to the adverse effects of space radiation,
taking into consideration age, sex, and other parameters.
Development of sensitive and reliable biological indicators which
can be obtained inflight by acceptable means and which can be related
to the degree of radiation exposure in space.
Development of sensitive techniques for detection and measurement of
the effects of radiation exposure following space flight.
Determination of acceptable radiation exposure limits for personnel
engaged in activities in space.
Research on the shielding problem and development of radiation
protection standards.
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